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Abstract 
 
 
 
Preserving the entire set of hereditary instructions necessary for life of 
every organism, genome integrity and identity maintenance is a serious 
concern for cells. Genomic DNA is continuously endangered by 
exogenous and endogenous factors and one of the most common 
source of genome instability was recently detected to be the 
misincorporation of ribonucleotides (rNTPs) during DNA synthesis. 
RNA is more susceptible than DNA to spontaneous hydrolysis, so the 
presence of rNMPs in the genome may render chromosomes more 
unstable. Moreover, embedded rNMPs induce replication forks stalling 
and alter the B-conformation of a dsDNA, resulting in replication 
stress. Normally, rNMPs in DNA are processed by Ribonuclease H 
(RNase H) enzymes, which cleave the RNA of RNA:DNA hybrids 
allowing the reconstruction of a dsDNA molecule. Cells lacking 
RNase H activity can survive thanks to the Post-Replication Repair 
mechanism, which includes an error free pathway, the Template 
Switch, and a more mutagenic pathway that relies on the ability of 
special enzymes to replicate across damaged DNA, the Translesion 
Synthesis (TLS). Here, we focus on the contribution of the three TLS 
Polymerases (Rev1, Pol  and Pol ) to genomic-rNMPs tolerance and 
incorporation. We previously demonstrated that Pol  efficiently 
replicates rNMPs-containing DNA and that Rev1 plays a non-catalytic 
role in supporting this function (Lazzaro et al. 2012). In this study we 
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observed that Rev1 has also a non-catalytic role in preventing Pol  
function. Surprisingly, the polymerase activity of Pol  appeared to be 
toxic for cells where dNTP pools, necessary for replication, are 
downregulated by hydroxyurea (HU), and lead to cell death when the 
RNase H is missing. Furthermore, we provide evidence that, in our 
sperimental conditions, Pol  toxicity is due to its tendency to 
introduce rNMPs during the TLS when the dNTP levels are low. Our 
findings describe an unexpected mechanism for TLS that could be 
relevant to replication stress in cells defective in RNase H, including 
humans stricken from diseases associated with RNase H defects like 
the Aicardi-Goutieres Syndrome (AGS). AGS is an autoimmune 
disease characterized by high levels of interferon  in the serum and 
cerebrospinal fluid. Due to the fact that identified mutations fall in 
genes implicated in nucleic acid metabolism or signalling, and that an 
emerging source of immunostimulatory nucleic acids are fragments 
derived from endogenous retroelements, a recent hypothesis states that  
the pathological immune response could be driven by aberrant 
accumulation of retroelements intermediates. We then decide to use 
S.cerevisiae as model system to investigate the role of RNase H2 in 
retroelements mobility and try to link it to the possible molecular 
origin of AGS. We found that yeast RNase H can block the 
retrotransposition process and, once replaced yeast enzymes with wild 
type or AGS mutated forms of human RNase H2, we noticed that one 
of the three tested mutations causes the loss of the RNase H protective 
function against the mutagenic potential of retroelements. Even if 
preliminary, these findings could guide the way to better understand 
the molecular causes of AGS. 
 5 
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1. DNA damage and Genome Instability 
 
Since the discovery of the DNA as the molecule that encodes the 
genetic information more than a half century ago, the mechanisms that 
protect it, then ensuring its faithful transmission across the generations, 
have been the subject of extensive investigations.  
In all living cells DNA molecules are continuously attacked by 
numerous factors, endogenous and environmental, that threaten their 
stability. The chemistry and the biology of DNA damage is very 
complex and the variety of DNA lesions is enormous, but fortunately 
nature evolved a multitude of strategies for repairing most of damage 
or, at least, mitigating its potentially lethal effect caused by 
interference with normal DNA metabolism (Fig. 1). 
The failure of a cell to maintain the integrity of its genomic DNA is 
reflected in the concept of “genome instability”, a condition 
characterized by the quick accumulation of different genetic 
alterations, ranging from point mutations to gross chromosomal 
rearrangements (Aguilera and Gómez-González 2008). 
Genome instability is present in almost all human cancers and is 
considered a key driving force in tumorigenesis (Loeb 1991) because, 
in order to develop, a cancer needs a strong accumulation of mutations 
(Hanahan and Weinberg 2011). 
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Surprisingly, it has been estimated that DNA damage associated with 
endogenous elements is more extensive than damage caused by 
environmental factors (Purohit and Basu 2000). In fact, the primary 
source of genomic damage is the chemical ability of DNA to react with 
molecules present in the surrounding cellular environment, like water 
and oxygen, resulting in multiple “spontaneous” lesions. For example, 
the deamination of four of the five bases that assemble the DNA 
polymer (cytosine, adenine, guanine and 5-methylcytosine) occurs 
inherently in pH- and temperature-dependent reactions of DNA and 
Figure 1: DNA damaging agents and repair systems 
The most common source of DNA damaging agents are illustrated at the top, in the 
middle are reported examples of induced DNA lesions and on the bottom the most 
relevant DNA repair mechanisms involved in their removal (from Hoeijmakers 
2001). 
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results in the conversion of the stricken bases to uracil, hypoxanthine, 
xanthine and thymine, respectively (Friedberg et al. 2006). Among the 
endogenous species that injure cellular DNA there are reactive oxygen 
species (ROS) and reactive nitrogen species (RNS), continuously 
produced as a consequence of normal metabolic activities like 
mitochondrial respiration.  
Other types of endogenous DNA damage are depurination (and to a 
lesser extent depyrimidination) that originate from the hydrolysis of 
the glycosidic bonds that hold together the nucleobase and deoxyribose 
sugars, thus leading to the formation of apurinic (or apyrimidinic) 
sites. 
On the other side, among the external causes of DNA damage there are 
solar UV radiation and ionizing radiation. Sunlight is considered the 
most powerful and ubiquitous physical carcinogen in our natural 
environment (D’Orazio et al. 2013); indeed, the UV portion of the 
solar spectrum in the 100- to 320-nm region can be directly absorbed 
by DNA, producing covalent links between two adjacent pyrimidine 
bases and leading to the formation of cyclobutane pyrimidine dimers 
(CPDs) and 6-4 photoproducts. Ionizing radiation is routinely used in 
medical diagnostic and chemotherapeutic applications. There are 
different forms of radiation that generate a variety of DNA lesions that 
include double- (DSB) and single-strand breaks (SSB), as well as 
oxidatively modified nucleobases and deoxyribose moieties. 
Moreover, apart from endogenous or environmental sources of DNA 
damage, a very serious threat to genome integrity comes from the 
DNA metabolism itself: the two main cellular processes involving 
DNA, namely transcription and replication, represent a potential 
State of the art 
 8 
source of chromosome breakage. The so-called replication stress and 
subsequent replication errors or replication failures appear to be the 
main origins of genome instability (Kunkel 2004, Gorgoulis et al. 
2005, Aguilera and Gómez-González 2008, Halazonetis et al. 2008).  
 
 
1.1.  DNA Replication Stress and Fork Stability 
 
In eukaryotes, DNA replication starts at thousands of individual 
replication origins that form bidirectional replication forks. Once 
origins fire and replication begins, the cell has to monitor several 
parameters, like its speed, the accuracy, the consumption and 
distribution of different required resources such as nucleotides and 
replication factors, to complete the process in an efficient manner. 
When a replication fork encounters a physiological or environmentally 
created obstacle on the template strand, its movement is temporarily 
compromised and this situation is termed “fork stalling” (Carr et al. 
2011). Once the obstacle is removed, DNA synthesis can restart. Since 
the DNA replication fork is asymmetric, it is known that injuries into 
lagging-strand template represent trivial obstacles to replication fork 
progression because DNA synthesis is already discontinuous and 
would leave a gap with a 5’ primer end. On the contrary, injuries into 
the leading-strand template chain induces a more noteworthy 
interruption of DNA synthesis and requires the additional step of 
repriming to resume the process. 
The direct consequence of a stalled fork formation is the unhooking of 
the replicative helicases from the polymerases, which leads to the 
Part I 
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accumulation of highly vulnerable single-stranded DNA stretches and 
then to replication stress (Carr et al. 2011).  
The stabilization of stalled forks is an important factor in the 
maintenance of the genome stability and a pivotal role is played by the 
DNA damage checkpoint protein kinases Mec1/Rad3/ATR, 
Rad53/Cds1 and Chk1 (Zegerman et al. 2009, Branzei et al. 2009). The 
pathways that result from these regulators prevent the worsening of the 
situation to the so-called “fork collapse” (Lopes et al. 2001). This 
phenomenon arises when the replisome is no longer associated with 
the site of DNA synthesis. The replisome contains the full range of 
replication proteins: the three replicative polymerases (eukaryotic Pol 
, Pol  and Pol ), the sliding clamp PCNA, the MCM replicative 
helicase and a range of accessory factors (Yao et al. 2010). Once a fork 
collapses, rebuilding and restarting a replisome can lead to 
rearrangements and cell death with mechanisms involving a variety of 
DNA transactions, engaging exonucleases, endonucleases and 
helicases that process newly replicated strands. Processing can form 
any of several structures, including large regions of ssDNA, a 
“chicken-foot” structure that resembles a Holliday Junction potentially 
cleavable to form a DSB (Postow et al. 2001), a structure called 
hemicatenane formed by a template-switch mechanism, and a structure 
recently termed “closed-fork” (Fig. 2) (Carr et al. 2011).  
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1.2.  DNA polymerases fidelity and replication errors 
 
The accuracy of DNA replication is a key aspect required for the 
correct transmission of an intact genetic information. Errors in DNA 
synthesis, although important for evolution, represent a source of DNA 
replication stress and may become major causes for cancer 
predisposition and genetic diseases. 
There are several families of DNA polymerases, grouped depending on 
the percentage of homology shared: A, B, C, D, X, Y and RT. In 
bacteria, C-family polymerases carry out the bulk of genomic DNA 
synthesis, while in eukaryotes B-family polymerases acquire this task 
(Pavlov et al. 2006, Kunkel 2009). These principal replicative DNA 
polymerases necessitate both speed and accuracy to replicate large 
genomes in an efficient and faithful manner. 
Figure 2: Structure of replication forks. 
A fork that is stalled by a barrier such as DNA damage (red X) undergoes one of 
several fates: restart beyond the fork to form a gap; regression to form a chicken foot; 
template switch to form a hemicatenane; DNA breakage to form a DSB; or a template 
switch to form a “closed fork” (Adapted from Carr 2011). 
Part I 
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Many different biochemical mechanisms safeguard the fidelity of 
replicative polymerases: selectivity for the insertion of the correct 
nucleotide provided by base-base hydrogen bonding, water exclusion 
from the catalytic site, and above all a steric selection on base pair 
shape and size within the active site (Kunkel 2004). Moreover, DNA 
replicative polymerases usually have the ability to proofread the 
insertion and detect mistakes. This editing (proofreading) function uses 
an exonuclease activity to immediately remove most mistakes. The 
measure of how accurately a DNA polymerase selects and proofreads 
the correct nucleotide is termed its fidelity. 
However, the stable insertion of incorrect nucleotide during DNA 
synthesis can happen and it results in nucleotide mismatches. It was 
estimated that the base substitution error rate of replicative 
polymerases in vivo is in the range of 10
–7
 to 10
–8
 (Schaaper 1993, 
Loeb 1991).  
Nonetheless, other specialized DNA polymerases exist: they copy only 
short segments of DNA during DNA repair processes or Translesion 
Synthesis (TLS) and thus do not require the same level of speed and 
accuracy as the replicative enzymes. TLS polymerases of the error-
prone Y-family, for example, are deployed to bypass replication-
blocking lesions (Pavlov et al. 2006, Kunkel 2009), meaning that 
bypass of the damage takes place at a potentially mutagenic cost; 
another example is represented by reverse transcriptases (RT), which 
catalyze both RNA- and DNA-dependent DNA synthesis of retroviral 
genomes (Sarafianos et al. 2009). 
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1.3.  Misincorporation of ribonucleotides in DNA 
 
The insertion of an incorrect nucleotide into the genome depends not 
only on the failure of polymerases to comply with the rule of 
complementarity between the bases of the two DNA strands. An error 
can arise even when these enzymes do not succeed in the 
discrimination of the identity of its sugar component (Joyce 1997).  
All cells contain two types of nucleotides, which are the essential 
building blocks of nucleic acids, DNA and RNA: deoxyribonucleotides 
(dNTPs) and ribonucleotides (rNTPs) respectively. dNTPs derives 
from rNTPs and this conversion is catalyzed by Ribonucleotide 
Reductase (RNR), whose enzymatic activity corresponds to the 
protonation/elimination of the substrate's 2’-hydroxyl group (Cerqueira 
et al. 2006) (Fig. 3).  
 
 
 
The two classes of nucleotides have very similar structures, differing 
only by a little chemical group at the second carbon in the ribose ring, 
an hydroxyl group in rNTPs and a hydrogen atom in dNTPs. It is thus 
Figure 3: General reaction catalyzed by ribonucleotide reductases. 
Hydrogen atom removal from the sugar by the enzyme’s thiyl radical and the 
subsequent radical rearrangements result in the loss of the 2’-OH group in the 
form of water. The reducing equivalent for the reaction differs depending on RNR 
class. (Adapted from Sintchak et al. 2002). 
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reasonable to think that the selection of the correct substrate represents 
a challenge for polymerases. 
Indeed, several studies have shown that the overall discrimination 
against rNTPs insertion is not 100% efficient and that they can be 
frequently misincorporated in genomic DNA during DNA synthesis; it 
has been estimated that more than 10.000 or more than 1.000.000 
rNTPs are incorporated, respectively, into yeast and mouse genomes 
during each cell cycle. So, ribose contamination appears to be the most 
frequent source of cellular DNA damage in eukaryotic cells (Reijins et 
al. 2012, Nick McElhinny et al. 2010). 
Moreover, just as the probability of base misincorporation and 
misalignment depend on the absolute and relative cellular 
concentrations of the four dNTPs (Kumar et al. 2010), the probability 
of rNTP insertion and stable incorporation in DNA also varies with the 
cellular concentrations of rNTPs and dNTPs. Measurements in yeast 
(Nick McElhinny et al. 2010) and mammalian cells (Traut et al. 1994, 
Ferraro et al. 2010) indicate that rNTPs concentrations are much higher 
than dNTPs concentrations (36- to 190-fold in S. cerevisiae depending 
on the nucleotide). This greatly increases the chances that rNTPs will 
be incorporated into DNA, despite the strong polymerase 
discrimination against this substrate. This point is nicely illustrated in a 
study (Nick McElhinny et al. 2003) regarding the human DNA 
polymerase , an enzyme that fills 1–2 nucleotide gaps during non-
homologous end joining of double strand breaks (DSBs). Increasing 
the rNTP:dNTP ratio to that estimated in mammalian cells resulted in a 
several-fold increase in rNTPs incorporation in vitro. This observation 
led also to the suggestion that rNTPs may be frequently incorporated 
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during gap-filling synthesis associated with DNA repair, especially in 
non-proliferating cells where dNTPs concentrations are low and 
rNTP:dNTP ratios are high (Nick McElhinny et al. 2003). 
Supported by these facts, other experiments in S. cerevisiae suggested 
that rNMPs misincorporation occurs randomly throughout the entire 
genome, even if some differences were observed mainly depending on 
the sequence context in vitro (Nick McElhinny  et al. 2010a, Nick 
McElhinny et al. 2010b). However, it has only recently been 
appreciated in yeast that rNMPs in both genomic and mitochondrial 
DNA are not randomly distributed and that hotspots of rNMP 
incorporation are positioned in specific sequences present in multiple 
copies, such as ribosomal DNA repeats and the yeast retrotransposon 
(Ty) (Clausen et al. 2015; Reijns et al. 2015; Koh et al. 2015; Daigaku 
et al. 2015). Moreover, through different rNMP-mapping methods, 
these studies revealed that more extensive rNMP incorporation occurs 
during leading strand synthesis by Pol  and confirmed that sites of 
incorporation are influenced by sequence context. As a consequence, 
despite rNMPs are typically viewed as mutations, their presence in 
DNA could have also a non deleterious role. 
A possibile physiological function for genomic rNMPs have been 
proposed in the fission yeast Schizosaccharomyces pombe, where the 
incorporation of rNTPs can occur via a site-specific mechanism: at the 
mat1 locus an imprint consisting of two rNMPs is incorporated into 
DNA during replication, in order to direct recombination events that 
eventually result in mating-type switching (Vengrova et al. 2006). 
Additional processes are known in which rNTPs play an important role 
when incorporated into the genome. They are intentionally introduced 
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into DNA by RNA primase-dependent synthesis of RNA primers that 
initiate Okazaki fragments during lagging strand replication. These 
rNMPs are removed during Okazaki fragments maturation (Rossi et al. 
2006, Burgers et al. 2009). Moreover, recent findings suggest that the 
presence of rNMPs may help metabolic processes that need to 
recognise the newly synthesized DNA strand; in fact, a single rNMP 
located near a mismatch can act as an initiation site for the Mismatch 
Repair system in human cell extracts, and Ribonuclease H2 (RNase 
H2) is crucial for efficient MMR on the leading strand in vivo 
(Ghodgaonkar et al. 2013). 
In any case, the main feature that renders the DNA a good template for 
storing the genetic information is its stability; so it is supposed that 
rNMPs can stay within the DNA molecule only temporarily and have 
to be removed before the DNA synthesis restarts. When accumulated 
at excessive levels, in fact, they might become a danger for a cell for 
several reasons.  
First of all, the chemical nature of rNTPs represents per se a challenge 
to genome stability, because the reactive hydroxyl group at the 2’ 
position of the ribose ring sensitizes the DNA backbone to cleavage, 
making it more vulnerable to spontaneous hydrolysis (Li and Breaker 
1999). 
In addition, many structural studies (Egli et al. 1993, Jaishree et al. 
1993, Ban et al. 1994, Ban et al. 1994, Wahl et al. 2000) indicate that 
RNA contamination of a double-stranded DNA causes alterations in 
the DNA helix shape, promoting a switch from the B- to the A-form 
and possibly interfering with the functionality of molecular 
mechanisms based on protein-DNA interactions. Also the proper 
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assembly of nucleosomes is negatively impacted by rNMPs in the 
genome, where having 5% or greater rNMPs content in DNA abolishes 
nucleosome formation (Hovatter et al. 1987). Stunningly, it has 
recently been observed that even a single rNMP embedded in duplex 
DNA can result in a helix perturbation at the RNA:DNA base stack 
which can modify protein recognition and binding (Gao et al. 2014, 
Tumbale et al. 2014) (Fig. 4).  
Finally, genomic rNMPs pose a serious threat to the replication 
process, acting as a physical obstacle to replication fork progression, 
when embedded into the template strand. In vitro assays demonstrated 
that replicative polymerases stall when rNMPs are present in template 
DNA strand, and in budding yeast and mammalian cells it was 
observed that irreparable genomic rNMPs cause replication stress 
(Nick McElhinny et al. 2010, Lazzaro et al. 2012, Pizzi et al. 2015).  
 
 
 
Normally cells try to limit genomic accumulation of rNTPs first 
preventing their stable insertion. This is possible because of a clash 
between the 2’-oxygen atom of the rNTP and the “steric gate” residues 
of the replicative polymerases (Brown et al. 2011); most DNA 
polymerases in fact strongly reject nucleotides with modifications of 
the 2’-deoxyribose sugar via a simple steric exclusion model: the small 
Figure 4: Structure of DNA 
with an embedded rNMP. 
Aligned structures of 12nt DNA 
molecule (green) and a DNA 
molecule (blue) with an 
embedded ribonucleotide (red) 
 (Adapted from Potenski et al. 
2014). 
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hydrophobic pocket in the nucleotide-binding site of these enzymes 
does not accommodate the 2’-hydroxyl group of rNTPs (Joyce 1997). 
Moreover, most high fidelity polymerases possess 3’-5’ exonucleolytic 
proofreading activity to excise nucleotides carrying the wrong sugar, 
as well as the wrong base (Williams and Kunkel 2014). 
To cope with the addition of rNMPs by replicative polymerases, cells 
can use a specific repair system designed to detect and remove rNTPs 
from dsDNA, the Ribonucleotide Excision Repair (RER) (examined in 
depth below). This mechanism relies on a rNMP-specific endonuclease 
that can recognise even a single rNMPs embedded in dsDNA, called 
Ribonuclease H2 in eukaryotic cells, and results in the correct 
resynthesis of the rNMP/rNMPs-containing DNA patch (Williams et 
al. 2014).  
In addition to this pathway, a backup mechanism based on 
topoisomerases I ability to target erroneous rNMPs has been recently 
identified in yeast, even if its activation can compromise genome 
integrity, causing short deletions in repeated sequences (Nick 
McElhinny et al. 2010, Clark et al. 2011, Kim et al. 2011). 
Topoisomerase I (Top1), whose primary role is to regulate DNA 
supercoiling through the production of transient SSBs, can recognize 
and cleave misincorporated rNMPs (Williams et al. 2013), but after the 
hydrolysis of the 3’-bond at an internal rNMP, the 2’-OH group causes 
the intramolecular hydrolysis of the enzyme bond forming a 2’-3’ 
cyclic phosphate at the nick site instead of maintaining a covalent bond 
between Top1 and the DNA. The subsequent removal of the nucleotide 
carrying this cyclic phosphate would then cause slippage and 
consequent short deletions (Kim et al. 2011, Williams et al. 2013). 
State of the art 
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However, new evidences shows that Srs2 helicase can repair Top1-
induced mutations originating from misinsertion of rNTPs in DNA. 
According to the model, Srs2 can unwind DNA from the 5’-OH end of 
the nick produced by Top1, interact with Exo1 and stimulate its 
exonuclease activity; the resulting gap is then filled by a DNA 
polymerase in an error-free manner (Potenski et al. 2014). 
 
 
2. Cellular response to DNA damage 
 
Damaged DNA must be removed for the DNA code to be read 
properly. During evolution cells have developed a complex network of 
coordinated mechanisms that uninterruptedly detect the lesions, signal 
their presence and improve their repair. In eukaryotic cells, the 
activation of DNA repair mechanisms, specific for different types of 
lesions, is most of the time combined with the activation of 
surveillance mechanisms named checkpoints; they respond to genomic 
perturbations by arresting the cell cycle and also by further promoting 
DNA repair (Hustedt et al. 2013; Lim et al. 2000).  
Collectively, these two types of systems are commonly defined as 
components of the cellular DNA damage response (DDR) (Fig. 5). The 
importance of DDR in maintaining genome integrity is underlined by 
the observation that defects in either DNA repair pathways or DNA 
damage checkpoints cause cell sensitivity to DNA-damaging agents 
and genome instability, and inherited mutations in many human DDR 
components are associated with cancer-predisposing syndromes 
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(Hoeijmakers 2001, Kennedy and D’Andrea 2006, Kerzendorfer and 
O’Driscoll 2009, Jackson and Bartek 2009). 
 
 
 
 
2.1  DNA damage checkpoints 
 
DNA damage checkpoint responses are responsible for the tight 
feedback regulation of cell cycle progression and frequently referred to 
as G1/S, S-phase and G2/M checkpoints. DNA damage leading to 
structural changes is initially detected by sensor molecules that are 
largely operative in all phases of the cell cycle. After sensing the 
damage, with the help of mediator proteins, the signal is passed on to 
Figure 5: Overview of the DNA damage response. (from Jackson and Bartek 2009). 
State of the art 
 20 
transducer proteins. At this point, the transducers modify direct or 
indirect mediators of cell cycle progression as their effector molecules 
by phosphorylation, possibly resulting in proteolytic degradation. If 
phosphorylated or absent, effector molecules cannot promote the 
transition through cell cycle phases, thereby establishing a cell cycle 
phase-specific delay or arrest. 
Following DNA repair, when the damage has been removed, 
the checkpoint pathway is inactivated in a process termed recovery that 
allows cell cycle progression. A related but genetically distinct 
process, the adaptation, controls cell cycle re-entry in the face of 
unrepairable damage. 
 
 
2.1.1. The recognition of the damage: signals and sensors 
 
Because many different kind of injuries can damage the DNA 
molecule, cells evolved a specific mechanism by which the checkpoint 
cascade can be activated independently of the lesion type. The current 
model suggests that lesion processing by DNA repair mechanisms 
produces a common DNA intermediate that can be recognized by the 
apical checkpoint factors. Several evidences suggest that this common 
intermediate comes from stretches of ssDNA generated either by the 
functional uncoupling of replicative helicases and polymerases during 
fork stalling or by nucleolytic processing of DNA lesions (Aparicio et 
al. 1999, Paulsen et al. 2007, Giannattasio et al. 2004, Giannattasio et 
al. 2010). Indeed, the regions of ssDNA are quickly coated by 
replication protein A (RPA) that is itself a target of budding yeast 
Part I 
 21 
Mec1, the central phosphoinositide 3-kinase (PI3K)-related protein 
kinase acting as a DNA damage sensor. RPA is able to recruit Mec1 
also via its co-factor Ddc2; indeed, Ddc2 foci demonstrate the 
accumulation of the Mec1-Ddc2 complex at sites of repair (Melo et al. 
2001, Rouse et al. 2002).  
Another factor recruited on DNA is needed for checkpoint cascade 
activation: the Rad17-Mec3-Ddc1 complex. This ring-shaped 
heterotrimer is loaded at the 5’ ssDNA-dsDNA junctions adjacent to 
RPA-coated ssDNA by Rad24 and Rfc2-5 proteins (Majka et al. 
2006a). It was demonstrated that the Ddc1 subunit can directly activate 
Mec1 (Majka et al. 2006b) and also recruit another protein, Dpb11, 
which further stimulates Mec1 activity (Puddu et al. 2008). 
Colocalization of Mec1-Ddc2 and Rad17-Mec3-Ddc1 complexes is a 
critical step for the checkpoint activation (Bonilla et al. 2008). 
Interestingly, both in yeast and mammalian cells it was shown that 
forced tethering of sensor proteins to chromatin is sufficient to elicit 
the DDR cascade even in absence of DNA damage (Bonilla et al. 
2008; Soutoglou and Misteli 2008). 
 
 
2.1.2. The transduction of the signal: adapters and 
mediators 
 
Once apical kinases are activated, the signal is transduced and 
amplified by phosphorylation and activation of numerous targets 
globally called mediators. In particular, in budding yeast two 
serine/threonine kinases are thought to be key regulators of the DNA 
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damage checkpoint response: Rad53 and Chk1. The activation of these 
mediators requires the presence of adaptor proteins, the most important 
of which is Rad9 (Schwartz et al. 2002, Naiki et al. 2004, Blankley and 
Lydall 2004). Activated Rad53 and Chk1 can phosphorylate their 
downstream targets, then modulating their activity; moreover, two or 
more molecules of Rad53 can autophosphorylate in-trans, resulting in 
full kinase activation (Pellicioli and Foiani 2005). Therefore, since 
Rad53 phosphorylation level correlates with its kinase activity, damage 
dependent Rad53 phosphorylation is generally used as a marker of the 
signal transduction cascade activation (Pellicioli et al. 1999). 
Changes to chromatin structure, including covalent modification of 
histone proteins, are known to occur during DNA-damage responses. 
In particular, active Mec1 can phosphorylate the S129 residue of 
histone H2A, demarcating large chromatin domains around the site of 
DNA lesion. This modification  is thought to create a specific platform 
for recruitment and/or retention of DNA damage repair and signaling 
factors (Redon et al. 2003), including for example Rad9 (Granata et al. 
2010; Javaheri et al. 2006). 
 
 
2.1.3. The cell response: transducers and effectors 
 
Checkpoint responses are multifaceted and integrate cell cycle arrest 
with DNA repair regulation. In yeast three checkpoint pathways were 
identified, which elicit different responses according to the cell cycle 
phase in which the cell experiences DNA damage (Nyberg et al. 2002): 
G1 checkpoint, S-phase checkpoint and G2/M checkpoint. 
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The first one slows down the entry in S phase, thus preventing the 
replication of a damaged DNA: the main effector molecule, 
phosphorylated by Rad53, is Swi6 transcription factor, whose 
modification inactivates the Swi6/Swi4 complex responsible for the 
transcription of CLN1 and CLN2 (Sidorova and Breeden, 1997), 
preventing the G1/S transition. 
The S-phase checkpoint slows down DNA synthesis, stabilizes the 
replication fork and promotes alternative replication systems 
(Paulovich and Hartwell 1995). Probably, the best example of the S-
phase checkpoint is when cells experience DNA damage, or nucleotide 
starvation, when entering S-phase: in these cases, replication fork 
stalling activates the checkpoint thanks to proteins associated to the 
fork itself, among which Sgs1 helicase, Pol2 subunit of DNA 
polymerase, Dpb11 and Drc1 proteins, and RFC subunits 2, 3, 4 and 5 
(Nyberg et al. 2002); moreover the S-phase checkpoint inhibits 
additional origin firing (mainly late replication origins) and 
recombination activities at the fork (Branzei and Foiani 2006). In 
yeast, indeed, it was shown that Rad53 phosphorylates Sld3 and Dbf4 
with the consequence to block further origin firing (Zegerman et al. 
2010). 
Lastly, the G2/M checkpoint halts the cell cycle before mitosis, 
preventing the segregation of damaged chromosomes (Weinert et al. 
1998): Chk1 phosphorylates Pds1, preventing its degradation, a critical 
step to achieve chromosome segregation (Sanchez et al. 1999); Rad53 
also promotes Pds1 stabilization by preventing its interaction with 
Cdc20 and its subsequent ubiquitylation by the APC/C
Cdc20
 complex 
(Agarwal et al. 2003). Moreover, Rad53 inhibits mitotic exit 
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phosphorylating also Cdc5, thus preventing APC/C
Cdc20
 activation and 
the degradation of mitotic cyclins (Sanchez et al. 1999). 
 
 
2.2. DNA repair pathways 
 
Due to the great diversity of the DNA injuries, several specialized 
repair pathways have evolved and it is increasingly clear that there is a 
remarkable overlap between them in terms of lesions that each can deal 
with. This functional redundancy underlines the importance of these 
pathways in the maintenance of genome integrity. 
The S-phase checkpoint has a central role in stimulating the repair 
processes and, in general, these two mechanisms are closely 
connected.  
The simplest repair mechanism is the so called Direct Reversal of 
DNA Damage: it consists of a single-step reaction like the 
photoreactivation of a cyclobutane pyrimidine dimer, which is the 
major product of UV radiations, by a specific DNA photolyase in a 
light-dependent manner (Thoma 1999). In addition, in eukaryotes it is 
possible to identify five main repair pathways: Homologous 
Recombination (HR) and Non-Homologous End Joining (NHEJ), 
involved in the resolution of double strand breaks, Mismatch Repair 
(MMR), Base Excision Repair (BER) and Nucleotide Excision Repair 
(NER), responsible of the correction of lesions derived from cellular 
metabolism, strand misalignments and non-Watson-Crick base pairs. 
Moreover, recently an additional repair mechanism, called 
Ribonucleotide Excision Repair (RER), has been identified (Sparks et 
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al. 2012) to effectively cope with genomic rNMPs that represent 
potentially the most abundant noncanonical lesion into DNA (Nick 
McElhinny et al. 2010a).  
 
 
2.2.1. The Homologous Recombination Pathway 
 
HR is used for the error-free repairing of double-strand breaks (DSBs) 
during S or G2 phase of the cell cycle. In order to occur, the system 
needs a sequence-homologous partner to be copied during repair, so 
cells must have already replicated the DNA. The key step is 
represented by the exonucleolytic processing, also called resection, at 
the 5’ strand of the DSB ends, with the subsequent formation of 
ssDNA tails at the 3’ strand (Krogh and Symington 2004). This 
ssDNA tract allows the loading of different recombination proteins, 
primarily Rad51, required for the recognition of the homologous 
chromosome and the subsequent strand invasion. Extension of the 
invading strand on the sister template then replaces the sequence 
across the DSB with that of the sister chromatid, after which the 
extended strand returns to the original chromosome, in a process 
named resolution (Li and Heyer, 2008). 
 
 
2.2.2. Non-Homologous End Joining 
 
In NHEJ the broken ends are directly rejoined. This mechanism can 
occur at any time during the cell cycle, even if it occurs predominantly 
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during G1 or stationary phase, when a sister chromatid is not present to 
provide a template for homologous repair. In yeast it requires three 
protein complexes: MRX (Mre11-Rad50-Xrs2), Ku (Ku70-Ku80) and 
DNA ligase IV (Dnl4-Lif1-Nej1). They recognise, bridge and ligate 
the broken DNA strands (Jackson 2002). Additional processing factors 
are also used if the DNA termini require resection or polymerization to 
become ligatable (Ma et al. 2002, Wilson and Lieber 1999). Indeed, 
repair by this pathway can often be inexact, because of the frequent 
loss of few nucleotides before the rejoining. 
 
 
2.2.3. Mismatch Repair 
 
MMR system detects and removes mispaired nucleotides polymerised 
during DNA synthesis and insertion/deletion loops (IDLs) that can 
form by slippage during replication of repetitive sequences 
(Hoeijmakers 2001). It acts by catalyzing the excision of the mispair-
containing tract of nascent DNA and by promoting its error-free re-
synthesis. In eukaryotes, MutS  (Msh2-Msh6) and Mut  (Msh2-
Msh3) complexes have the role of recognition and verification of the 
mismatch and of recruitment of MutL  (Mlh1-Pms2) and MutL  
(Mlh1-Pms1) complexes. At this point MutL , translocating along 
DNA, recognises the damaged (neo-synthesized) strand thanks to the 
presence of a nick. Such nick is likely provided by the removal of 
Okazaki fragments on lagging strand, while it is still unclear how it is 
generated in leading strand (Jiricny 2006). A recent work demonstrated 
that it could be produced by the activity of RNase H2 at rNMPs 
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incorporated by the replicative polymerase  (Ghodgaonkar et al. 
2013). Removal of the mismatch containing strand can be then 
accomplished by Exo1 and the resulting gap is finally filled by DNA 
polymerase (Li 2008). 
 
2.2.4. Base Excision Repair 
 
BER system corrects base alterations derived from cellular metabolism 
like oxidative damages, deaminations, methylations or hydroxylations. 
It is based on the activity of several dedicated DNA N-glycosylases, 
specialized in the recognition of a specific base modification. Once one 
of these glycosylases recognizes the lesion, the erroneous base is 
released through cleavage of the glycosidic bond that holds together 
the base and the deoxyribose, leaving thus an abasic site within the 
DNA molecule. Subsequently, an apurinic/apyrimidinic (AP) 
endonuclease nicks the DNA backbone immediately 5’ of the lesion. 
Yeast has two AP endonucleases, Apn1 and Apn2. In the short-pach 
BER (that is the main pathway) one-nucleotide gap filling is performed 
by DNA pol  that, removing the 5’-terminal baseless sugar, leaves a 
nick to be sealed by DNA ligase 3. In the long-patch BER, Pol /Pol  
re-synthesize a 2-10 nucleotides gap, the endonuclease Rad27 removes 
the flap generated by strand displacement, and DNA ligase 1 seals the 
nick (Hoeijmakers 2001). 
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2.2.5. Nucleotide Excision Repair 
 
NER system corrects a large variety of helix-distorting lesions that 
interfere with base pairing and impair nuclear functions such as 
replication and transcription. It can also provide an alternative 
mechanism to repair AP sites and oxidized bases (Gellon et al. 2001) 
but, in general, damages faced by NER mainly come from external 
sources. Eukaryotes possess two different subpathways of NER: the 
first one, named global genome NER (GG-NER), removes lesions 
from non-transcribed DNA strands; the second, transcription-coupled 
NER (TC-NER), takes care of lesions occurring on the transcribed 
strand which prevent the proper gene transcription (Tornaletti et al. 
1999; Hanawalt 2002). 
GG-NER is initiated when, with the help of the Rad7-Rad16 complex, 
the trimeric complex composed of Rad4-Rad23-Rad33 senses the 
distortion of the DNA structure and unwinds a 10bp region around 
the lesion (Tapias et al. 2004). This DNA structure allows the 
positioning of TFIIH transcription factor, Rad14 and RPA in order to 
arrange the so called pre-incision complex and further open the DNA 
double helix. Subsequently, the Rad2 and Rad1-Rad10 endonucleases 
are recruited: Rad2 nicks 2-8 nt from the damage on the 3’side, while 
Rad1-Rad10 nicks 15-24 nt from the damage on the 5’ side (Evans et 
al. 1997). The lesion-containing fragment thus generated is released 
together with other NER factors. Lastly, repair synthesis fills the gap 
and DNA ligase 1 seals the nick (Thoma 1999; Lindahl and Wood 
1999). 
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On the contrary, TC-NER is triggered because the RNA polymerase 
itself signals the presence of a lesion. Indeed, it was demonstrated in 
yeast that Rad26 may be associated with RNA Pol II during 
transcriptional elongation; accordingly, its positioning to the site of the 
damage would result from stalling of the enzyme in an elongation 
mode (Malik et al. 2010). At this step, Rad26 and Rad28 displace RNA 
polymerase and recruit the other NER factors. Hereafter the pathway is 
identical to GG-NER (Hoeijmakers 2001). 
 
 
2.2.6. Repair of ribonucleotides embedded in the genome: 
Ribonucleotide Excision Repair 
 
The main enzyme of this pathway is the Ribonuclease H2 (RNase H2), 
an endoribonuclease able to cleave the phosphodiester bond between 
dNMP and rNMP, or two adjacent rNMPs, into a DNA duplex 
substrate. This enzymatic activity is present in all kingdoms of life, 
from retroviruses to humans (Crouch and Cerritielli 1998) and two 
types of RNases H exist: RNase H1 and RNase H2 (named RNase HI 
and HII in bacteria). In yeast, RNase H1 is a monomeric enzyme, 
while RNase H2 has three different subunits (Rnh2Ap, Rnh2Bp and 
Rnh2Cp). Of these subunits, only the 2A shows catalytic activity, 
while  2B and 2C have the role of providing a platform for the 
assembly of the complex, ensuring processivity and ability to interact 
with PCNA, an essential protein for DNA replication and repair (Chon 
et al. 2009). Mutations in RNase H2 are associated with the human 
Aicardi-Goutières syndrome, an autosomal recessive disorder that 
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could result from mishandling nucleic acids (see below). In mice with 
complete RNase H2 deficiency, accumulation of rNMPs in genomic 
DNA causes embryonic lethality due to the activation of the DNA 
damage response (Reijns et al. 2012, Hiller et al. 2012). On the 
contrary, yeast RNase H2 null mutant are viable (Lazzaro et al. 2012). 
RNase H1 and H2 have partially overlapping substrates, since RNase 
H2 shows an increased activity in yeast rnh1Δ deletion strains, 
possibly in order to compensate for loss of RNase H1 activity 
(Arudchandran et al. 2000). Indeed, RNase H1 hydrolyzes the RNA 
moiety when present in a tract of at least four rNMPs, while RNase H2 
is the only one able to incise even a single rNMP incorporated within a 
DNA molecule (Cerritelli and Crouch 2009) (Fig. 6). 
 
 
 
The RER pathway begins when RNase H2 recognizes rNMPs within 
DNA strands and cuts the backbone 5’ to an rNMP, creating a nick 
whose ends have a 3’-OH and a 5’-RNA-DNA junction. RNase H1 
Figure 6: cleavage patterns of RNase H enzymes. 
Three types of substrates are shown: a single ribonucleotides in a duplex DNA (top), 
four consecutive ribonucleotides residues (middle) and an RNA/DNA hybrid (bottom) 
that are cleaved differently by the two classes of enzymes (Adapted from Cerritelli and 
Crouch, 2009).  
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fails to substitute for RNase H2 in this RER reaction. Subsequently, 
strand displacement synthesis by Pol   occurs, with the help of PCNA 
and the RFC clamp loader. In this case, Pol ε is able to substitute for 
Pol  , but the reaction is slightly less efficient. FEN1 then excises the 
resulting flap containing the RNA-DNA junction, nicking 3’ to the 
rNMP containing segment (Rydberg and Game 2002). Exo1 can 
substitute for FEN1, even if less efficiently, but Dna2, able to only act 
on longer flaps, cannot substitute for FEN1. In order to complete the 
mechanism, the resulting nick is sealed by DNA ligase 1 (Sparks et al. 
2012) (Fig. 7). 
 
 
 
 
 
 
 
Figure 7: Ribonucleotide Excision Repair. (from Sparks et al. 2012). 
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2.3. Tolerance of DNA damage 
 
Albeit cells have many systems to restore their genome to its original 
sequence and structure, sometimes another kind of mechanisms are 
required. Indeed, when the repair pathways are saturated or incapable 
of replication-blocking lesions removal before the S-phase beginning, 
cell death could result.  
In emergency situations these mechanisms, collectively referred to as 
Post-Replication Repair (PRR) or DNA Damage Tolerance (DDT) 
(Friedberg 2005), facilitate cell survival by promoting the completion 
of the replication process, without mediating lesions repair, according 
to the “better safe than sorry” philosophy. DNA damage tolerance 
processes therefore also actively promote the generation of mutations 
and their transmission to the next generation (Andersen et al. 2008), 
but their task is not to protect the accuracy of the genetic information. 
In eukaryotes, PRR is accomplished by an error free pathway and a 
parallel, more mutagenic pathway: the Template Switching (TS) and  
the Translesion DNA Synthesis (TLS), respectively (Fig. 8).  
It is still poorly understood what determines the choice between TS or 
TLS, but decisive factors include the type of lesions, the extent of 
DNA damage and the phase of the cell cycle (Diamant et al. 2012; 
Huang et al. 2013). A recent study reveals that also topological 
changes, particularly the Hmo1-dependent DNA banding, can 
influence on the mode of tolerance (Gonzalez Huici et al. 2014).  
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2.3.1. Activation of the Post Replication Repair 
 
The RPA-coated ssDNA tracts, arranged as a consequence of fork 
stalling during DNA replication, act as a signal for the recruitment of 
the E3-ubiquitin ligase Rad18 to chromatin (Davies et al. 2008). 
Subsequently, also the E2-conjugating enzyme Rad6 is recruited and, 
together with Rad18, forms a stable heterodimer able to 
monoubiquitylate PCNA at the conserved residue Lys164 (Hoege et al. 
2002).  
PCNA is a key regulator of the tolerance pathway selection; its post-
translational modification directs bypass into the alternative 
Figure 8: DNA damage tolerance. A simplified scheme of the mechanisms of TLS 
and template switching. Following replication fork stalling at a DNA lesion (green 
star) the damage can be overcome using an alternative DNA template, that is the 
newly synthesised strand on the sister chromatid, or specialised DNA polymerases can 
directly replicate the lesion by TLS. On the left is represented what happens at the 
fork; on the right is shown  what happens at post-replicative gaps, generated far from 
the replicative fork because of the recovery of DNA synthesis downstream of the 
block (from Sale 2012).  
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subpathways (Fig. 9) (Ulrich and Walden 2010). Monoubiquitylated 
PCNA activates TLS system (Stelter and Ulrich 2003), but the single 
Ub mojety can be further extended by another E3-ubiquitin ligase, 
Rad5, and the E3-conjugating complex Ubc13-Mms2, allowing the 
formation of a polyubiquitin chain at Lys164 (Hoege et al 2002). 
Polyubiquitylation of PCNA triggers then the downstream steps of TS 
(Fig. 9). Importantly, PCNA ubiquitylation is a reversible process, 
allowing the PRR to be switched off once the lesions have been 
bypassed. In S. cerevisiae the role of Ub molecules removal is carried 
out by the ubiquitin protease Ubp10 (Gallego Sanchez et al. 2012). 
 
 
Figure 9: Post-translational modification of PCNA. PCNA can be modified by 
monoubiquitylation, polyubiquytilation or sumoylation, determining an error free or 
error prone outcome (from Sale 2012). 
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Moreover, during normal S-phase the replication sliding clamp can be 
modified at Lys164, and with low frequency at Lys127, by another 
molecule: small ubiquitin-related modifier (SUMO). In budding yeast 
this event is dependent on the activity of the E2 and E3 SUMO ligases 
Ubc9 and Siz1, respectively (Ulrich 2009), and has been associated 
with the activation of the DNA damage tolerance mechanisms (Hoege 
et al. 2002; Stelter and Ulrich 2003), supporting Rad18-mediated 
ubiquitylation in the presence of DNA damage (Parker and Ulrich 
2012). As a matter of fact, sumoylated PCNA attracts the 
antirecombinogenic helicase Srs2, which is able to displace the 
ricombinase Rad51 in order to avoid unwilled recombination and make 
room for other proteins like Rad18 (Papouli et al. 2005; Pfander et al. 
2005). 
 
 
2.3.2. Template Switching 
 
How polyubiquitylated PCNA promotes template switching is still 
mostly speculative. Reputedly, the polyubiquitin chain prevents the 
access of the TLS polymerases to the site of damage or even throw 
them out through direct interaction with the ubiquitin-binding motifs in 
the polymerases. This could allow access to the DNA of other proteins, 
thereby allowing template switching to occur. Another hypothesis is 
that polyubiquitylated PCNA acts as a scaffold by recruiting the 
enzymes that carry out template switching process. 
Anyway, this type of error-free bypass is mediated by a transient 
“template switching” in which the stalled nascent DNA strand takes 
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advantage of the newly synthesized, undamaged strand of the sister 
chromatid, using it as a template for replication across the DNA lesion.  
Two alternative template switching strategies exists: the Replication 
Fork Regression, in which after replication fork stalling, the parental 
DNA partially reanneals while the two newly synthesized strands do 
the same to form a structural rearrangement defined “chicken foot” 
(Sogo et al. 2002) (Fig. 8); and the Post-Replication Recombinational 
Repair, that is an homologous recombination-based lesion bypass 
triggered by sister chromatin invasion and branch migration across the 
damaged portion of the template.  
Both methods need the association of the two nascent DNA strands, 
followed by resolution of the intermediary structure via reverse branch 
migration in the first case, or cleavage of the Holliday junction, here 
specifically called sister chromatid junction (SCJ), in the second case. 
Even if these processes are not yet completely understood, it is 
becoming clear that a crosstalk exists between classical homologous 
recombination and template switching (Fig. 8). In effect, recent 
evidence has shown that the formation of SCJs depends on Rad5 and 
Rad18 proteins as well as on homologous recombination factors, like 
Rad51, and requires Pol -dependent DNA synthesis but not TLS 
polymerases (Branzei et al. 2008; Minca and Kowalski 2010; Vanoli et 
al. 2010). The processing of SCJs is eventually performed by the RecQ 
helicase complex Sgs1-Top3-Rmi1 (Cejka et al. 2012; Branzei et al. 
2008; Karras and Jentsch 2010). 
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2.3.3. Translesion DNA Synthesis 
 
TLS is a direct mechanism of bypassing unrepaired lesions, which 
includes several specific DNA polymerases capable of incorporating a 
nucleotide opposite to the lesions despite the conformational 
constraints that many of them may impose (Friedberg 2005; Prakash et 
al. 2005). These particular enzymes are present in organisms 
throughout all three domains of life. In contrast to the replicative DNA 
polymerases, they have a more spacious active site that allows the 
accommodation of large bulky adducts (Ling et al. 2001; Friedberg 
2005) which are unable to fit into the active site of their cousins; 
moreover, they are non-processive low-fidelity enzymes and have lost 
the proofreading exonuclease activity (Prakash et al. 2005; Friedberg 
et al. 2002). 
Although TLS polymerases are widely referred to as “error-prone” 
because all are notoriously mistaken on undamaged DNA, the fidelity 
of each of them relative to replicases is lesion specific. Some TLS 
polymerases are optimized to bypass one or a few types of lesions in a 
relatively error-free manner. This feature is strikingly clear in the case 
of Pol , which can accurately insert two adenines opposite a thymine 
dimer caused by UV irradiation, thus reducing UV-induced 
mutagenesis (Johnson et al. 1999; Kozmin et al. 2003; McCulloch et 
al. 2004). 
Yeast possesses three TLS polymerases: Pol , which is a member of 
the B family of DNA polymerases, the same including also replicative 
DNA polymerases; Rev1 and Pol , which belong to the Y family 
(Ohmori et al. 2001). 
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DNA Pol  is a heterodimer composed of the Rev3 catalytic subunit 
and the Rev7 accessory subunit, which enhances the polymerase 
activity of Rev3 by about 200-fold (Nelson et al. 1996b). Although it 
can sometimes insert nucleotides across damaged bases, it has a unique 
architecture to extend DNA synthesis from distorted DNA structures, 
such as mismatches that may result from inaccurate base insertion by 
another polymerase (Zhong et al. 2006; Lawrence 2004), methylated 
bases (Johnson et al. 2007), AP sites (Haracska et al. 2001b), oxidative 
damages (Johnson et al. 2003; Abdulovic and Jinks Robertson 2006) 
and DNA-protein crosslinks (De Graaf et al. 2009; Grogan and Jinks 
Robertson 2012). Moreover, in budding yeast Pol  actively replicates 
rNMPs-containing DNA template (Lazzaro et al. 2012). 
Despite the lack of conserved PCNA interaction motifs, Pol  exhibits 
increased lesion bypass activity in the presence of PCNA (Garg et al. 
Figure 10: Types of eukaryotic TLS polymerases and genes encoding their 
catalytic subunits.  
Other non-replicative polymerases exists, as Pol ,  and , members of the X 
family, and Pol , an A family member. They are capable of TLS in certain situations 
but they have other primary physiological functions  (from Lauren et al. 2009). 
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2005), probably because it generally works together with Rev1 
(Lazzaro et al. 2012). As a matter of fact, Rev3 subunit interacts with 
Rev1 in vitro and this interaction stimulates the ability of Pol  to 
extend mismatches and bypass specific lesions (Acharya et al. 2006; 
Guo et al. 2004). Also Rev7 is capable to mediate the interaction with 
Rev1 (D’Souza and Walker 2006, Acharya et al. 2005); moreover, it 
can bind to the 9-1-1 alternative processivity clamp, which participates 
in DNA damage signalling and checkpoint, and this interaction may 
facilitate the positioning of Pol  to the site of damage (Sabbioneda et 
al.2005). 
In contrast with the versatility of Pol , Rev1 has a polymerase activity 
that is restricted mainly to inserting a dCMP nucleotide across an 
undamaged template G and across a variety of DNA lesions, like 
abasic sites and adducted G residues (Lawrence 2004; Nelson et al. 
1996a); for this reason Rev1 is also defined as a deoxycytidyl 
transferase. In spite of this “shortcoming”, its catalytic activity is not 
necessary for the overcoming of many DNA alterations for which 
Rev1 function is required in vivo (Haracska et al. 2001b). Instead, the 
contribution of Rev1 to yeast cell’s resistance to DNA damaging 
agents and to mutagenesis mainly derives from its interactions with 
other proteins, as PCNA (Guo et al. 2006) and particularly other TLS 
polymerases: Pol  (D’Souza and Walker 2006) and Pol  (Acharya et 
al. 2007). Therefore, from these observations comes a model in which 
Rev1 acts as a scaffold for the recruitment and the coordination of 
various DNA damage tolerance factors at the site of lesion, rather than 
directly catalyze DNA synthesis across the lesion (Guo et al. 2003).  
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Finally, Pol  (also defined Rad30 in yeast) as formerly mentioned is 
endowed with the ability of accurately bypass particular types of DNA 
lesion, as cis-syn cyclobutane pyrimidine dimers resulting from UV 
radiation (Johnson et al. 1999; Kozmin et al. 2003; McCulloch et al. 
2004). In addition, it is also involved in the bypass of a broad spectrum 
of other lesions in vitro, such as 7,8-dihydro-8-oxoguanine (Haracska 
et al. 2000b), which is a common form of oxidative base damage, 
acetylaminofluorene-adducted guanine (Yuan et al. 2000), O
6
-
methylguanine (Haracska et al. 2000a), thymine glycol (Kusumoto et 
al. 2002) and adducts derived from cisplatin and oxaliplatin (Vaisman 
et al. 2000). Unexpectedly, on undamaged template this enzyme shows 
in vitro among the lowest fidelity of any DNA polymerase (Prakash et 
al. 2005; Matsuda et al. 2000).  
As the other TLS polymerases, the catalytic activity of  Pol  is 
regulated through protein-protein interactions; indeed, an important 
role is played by PCNA, which stimulates its activity in vitro 
(Haracska et al. 2001a). This interaction can be enhanced by the 
monoubiquitylation of PCNA; mutants disrupting its ubiquitin-binding 
domain in either budding yeast or mammalian Pol , cannot 
complement the UV sensitivity of cells lacking this enzyme (Bienko et 
al. 2005; Parker et al. 2007). Another binding partner of  Pol  is 
Rev1, but little is known about how this interaction affects its activity, 
except that the DNA synthesis activity of Rev1, but not of Pol η, seems 
to be enhanced in the complex in vitro (Acharya et al. 2007). 
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3. Molecular consequences of Ribonuclease H 
failure 
 
As previously anticipated, RNase H are the major enzymes able to 
hydrolyze the RNA mojety in RNA:DNA hybrids and are highly 
conserved during evolution. 
The in vivo roles of RNase H in eukaryotic cells are still not fully 
understood, and some differences exist among organisms. For 
example, in mammals, RNase H1 has been implicated in mitochondrial 
DNA replication while this role is not conserved in yeast (Cerritielli et 
al. 2003). Moreover, it is noteworthy that while in yeast the deletion of 
both types of RNase H is compatible with life, in mammalian cells 
their functionality is essential (Reijns et al. 2012, Cerritielli et al. 2003, 
Hiller et al. 2012).  
Apart from the involvement of RNase H2 in Ribonucleotide Excision 
Repair mechanism (described in detail in 2.2.6), which allows the 
removal of even single rNMPs embedded in dsDNA molecules, RNase 
H enzymes participate in many other cellular processes. 
It is known the involvement of RNase H2 in the processing of Okazaki 
fragments redundantly, at least in yeast, with Fen1 and the 
nuclease/helicase Dna2 (Rydberg and Game 2002, Ayyagari et al. 
2003). Furthermore, over-expression of RNases H1 has been 
associated with removal of R-loops (Huertas and Aguilera 2003). 
These are three-strand nucleic acid structures that form as a 
consequence of the annealing of the transcribed RNA on its template, 
thus generating an RNA:DNA hybrid and a displaced ssDNA strand 
(Aguilera and Garcìa Muse 2012). Moreover, a high-throughput RNAi 
State of the art 
 42 
screening identified the RNase H2A, containing the catalytic centre, as 
a factor that increase HIV replication in host cells (Genovesio et al. 
2011), thus supporting the hypothesis of a role of RNase H2 also in the 
regulation of endogenous retroelements metabolism (Rabe 2013). 
Finally, mutations in any of the human genes encoding for RNase H2 
subunits causes Aicardi-Goutières syndrome (Crow et al. 2006b).  
 
 
3.1. Aicardi-Goutières Syndrome 
 
Aicardi-Goutières syndrome (AGS) is a chronic inflammatory genetic 
disorder that typically affects newborns and infants and results in 
severe mental and physical handicap (Rice et al. 2007). It was first 
described in 1984 by Jean Aicardi and Françoise Goutières (Aicardi 
and Goutières 1984) as an early onset encephalopathy characterized by 
basal ganglia calcifications, white matter abnormalities and chronic 
cerebrospinal fluid (CSF) lymphocytosis. Few years later, Lebon 
(Lebon et al. 1998) added a further typical feature to the diagnostic 
profile of the syndrome: the presence of raised levels of interferon  
(INF ) in the CSF and serum in the absence of demonstrable 
infections of the central nervous system (CNS) (Rice et al. 2007). 
To date, only few hundreds of affected individuals worldwide have 
been classified since the genes responsible of the disease have been 
identified only recently and because AGS is likely to be misdiagnosed, 
as it mimics the symptoms caused by congenitally acquired viral 
infection. The severity of the neurological phenotype, although 
consistent among patients, presents a high level of variation. Patients 
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mostly present peripheral spasticity, dystonic posturing, truncal 
hypotonia and, almost all, are severely intellectually and physically 
impaired (Rice et al. 2007). 
AGS is genetically heterogeneous and up to now, seven genes have 
been involved in its pathogenesis: TREX1, encoding a DNA 
exonuclease, RNASEH2A, RNASEH2B and RNASEH2C, encoding 
the three subunits of the RNase H2, SAMHD1, encoding a dNTP 
triphosphohydrolase, ADAR1, encoding an adenosine deaminase and 
IFIH1, which encodes the cytosolic dsRNA receptor also called MDA5 
(Crow et al. 2006a, Crow et al. 2006b, Rice et al. 2009, Rice et al. 
2012, Rice et al. 2014, Oda et al. 2014). All these proteins are 
implicated in nucleic acid metabolism or signalling but the molecular 
origins of AGS are still unknown. However, the relationship between 
the mutations in the above cited genes with increased interferon  
activity in CSF and serum and the increased expression of interferon 
-stimulated gene transcripts in peripheral blood, strongly suggests 
that the interferon -mediated innate immune response is driven by 
aberrant accumulation of endogenous nucleic acids (Rabe et al. 2013, 
Crow and Rehwinkel 2009). 
Approximately, 60% of the AGS patients have mutations in the three 
genes encoding the RNase H2 complex subunits. Among the RNase 
H2 genes, the RNase H2B is the most frequently mutated, with the 
recurrent c.529G>A A177T substitution considered a mutation 
hotspot. This mutation is recurrently present in hetero compound with 
c.488C>T T163I mutation. RNase H2B mutations has been associated 
with a significantly later onset, lower mortality and relatively 
preserved intellectual function (Rice et al. 2007). 
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Conversely, the earliest appearance and most severely affected AGS 
patients carry mutations in the C and A subunits (Chon et al. 2009, 
Rice et al. 2007); in particular, missense mutation c.139G>A G37S in 
subunit A was demonstrated to severely impairs enzymatic activity 
(Crow et al. 2006b).  
 
 
3.2. Involvement of RNase H in autoimmunity 
 
In mammals, the detection of non-self nucleic acids, as that ones 
belonging to pathogens as viruses, by pathogen recognition receptors 
leads to the production of type I interferons (IFNs) (Akira et al. 2006), 
including IFN .  
Figure 11: Number 
and percentage of  
families with AGS 
with the seven 
identified 
mutations. 
Data collected in the 
recent study 
conducted by Crow 
group. 
D: dominant 
mutation. 
 (from Crow et al. 
2015). 
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However, although these molecules are a very important factor in 
cellular response to viral infection, uncontrolled production of IFNs 
can also induce pathological consequences, most notably the 
development of autoimmune diseases, as in the case of AGS. The 
discrimination of viral from self nucleic acids is not always perfect; 
indeed, different studies have ascertained that the defective processing 
of self-derived nucleic acids can cause serious IFN-dependent 
autoimmunity. For example, the deoxyribonuclease I (DNase I) 
deficiency in mouse causes a syndrome resembling the human 
systemic lupus erythematosus (SLE), characterized by multisystem 
inflammation commonly including the skin, kidneys, and joints 
(Napirei et al. 2000) and DNase I mutations in humans inducing 
decreased enzymatic activity are associated with SLE (Yasutomo et al. 
2001). Moreover, mutations in IFIH1, inducing the over-activity of the 
anti-viral helicase MDA5, has been recently associated to increased 
sensitivity to IFNs and increased IFN-induced gene expression in 
circulating blood cells from SLE patients (Robinson et al. 2011). 
In recent years, the IFN-stimulatory DNA (ISD) response has been 
discovered: it is a antiviral signalling pathway activated by cytosolic 
DNA, which can activate potent IFNs production through the 
activation of TANK-binding kinase 1 (TBK1) and IFN regulatory 
factor 3 (IRF3) (Ishii et al. 2006, Stetson and Medzhitov 2006). 
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In 2008, Stetson et al. investigated the mechanism underlying the 
autoimmune disease caused by Trex1 deficiency and observed, in 
mouse, that this protein is a negative regulator of the ISD response, 
because mice lacking both IRF3 and TREX1 relentlessly died; 
moreover, the study showed that fragments of endogenous 
retroelement DNA are potential Trex1 substrates, since they are 
accumulated in the hearts of Trex1-deficient mice; lastly, the sequence 
analysis of cytosolic DNA purified from cells of mice lacking Trex1 
revealed that fragments derived from endogenous retroelements were 
Figure 12: Cellular pathways stimulated by DNA molecules. 
The best characterized DNA-stimulated pathway is the one leading to IFNs 
production. Other pathways are the inflammatory NF-kB and inflammasome 
pathways, which stimulate expression of inflammatory genes and cleavage of pro-IL-
1  and IL-18, respectively. Intracellular DNA also stimulates autophagy, apoptosis 
and necrosis. (from Paludan et al. 2013). 
Part I 
 47 
abundantly represented, suggesting that the reverse-transcribed DNA 
of these elements can be metabolized by Trex1 (Stetson et al. 2008). 
Given that mutations in Trex1 and RNase H2 lead to very similar 
autoimmune diseases, and both are involved in AGS pathogenesis, a 
reasonable hypothesis is that they function in the same pathway, 
maybe sharing a common substrate: the DNA:RNA hybrid probably 
derived from endogenous retroelements. 
 
 
3.2.1. Transposition and retrotransposons 
 
The transposition is a particular type of genetic recombination which 
allows the integration, through at least two molecular mechanisms, of 
particular DNA sequences, called transposable elements (TEs), into the 
genome at a new position within the cell of their origin.  
TEs are divided in two major classes: DNA transposons and 
retrotransposons. DNA transposons can be excised and inserted into 
new genomic site; retrotransposons, on the contrary, have to replicate 
by forming an RNA intermediate, which is reverse-transcribed in order 
to obtain a cDNA molecule that can be inserted into a new genomic 
site (Ayarpadikannan and Kim 2014) (Fig. 13).  
Based on the presence of long terminal direct repeats (LTRs), 
retrotransposons are further divided in LTR and non-LTR transposons. 
The internal domain of retrotransposons encodes genes that are 
equivalent to retroviral gag and pol genes (Fig 13). Indeed, the purpose 
of the transcription phase is also to synthesize a template for the 
translation of the reverse transcriptase and nucleocapsid proteins, both 
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important for the transposition process (Curcio and Garfinkel 1991a). 
Retrotransposons resemble eukaryotic retroviruses in their structure, as 
well as in the way of replication: they form cytoplasmic virus-like 
particles (VLPs), which package the RNA transcript and where the 
reverse transcription process is circumscribed. 
 
 
 
Among the best characterized retrotransposons are the Ty elements of 
S. cerevisiae and, in particular, Ty1 has been long studied and then 
genetically modified in order to provide a tool to better understand its 
retrotransposition (Boeke et al. 1985, Garfinkel et al. 1988, Curcio and 
Garfinkel 1991a). Ty1 transcript, synthesized by cellular RNA 
polymerase II, contains two open reading frames (ORFs), TYA and 
Figure 13: Types and structure of transposable elements.  
DR: direct repeats; ITR: inverted terminal repeat; TSD: tandem site duplication; LTR: 
long terminal repeats.  (from Ayarpadikannan and Kim 2014). 
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TYB, encoding for nucleocapsid proteins of the VLPs and for protease, 
integrase, reverse transcriptase and a RNase H, respectively (Curcio 
and Garfinkel 1991a). 
There are about 30 Ty1 elements in the haploid yeast genome (Curcio 
and Garfinkel 1994) and Ty1 RNA is one of the most abundant mRNA 
species in yeast (Curcio et al. 1990). Despite this, in normal conditions 
these elements exhibit transpositional dormancy (Curcio and Garfinkel 
1991b) and this probably results from inhibition of one or more post-
transcriptional steps in the Ty1 replication cycle. The main 
characteristic of all TEs, that is their ability to move, can in fact cause 
genomic instability in many ways, either by insertion or by 
rearrangements in the genome that may have a large number of 
different effects on a cell, ranging from silent mutation to alternative 
splicing of any transcript. The site of insertion along the genome, 
indeed, appears to be random, even if the integration is particularly 
frequent in the region upstream of genes transcribed by RNA 
polymerase III (Ji et al. 1993). Cells have then evolved mechanisms to 
regulate transposition in order to reduce their mutagenic potential and 
several host factors can inhibit Ty1 transposition (Rattray et al. 2000, 
Picologlou et al. 1990). Among them, in 2001 Sholes et al. 
characterized the RTT genes, regulators of Ty1 transposition, which 
products block the post-transcriptional steps of the process. Many of 
these proteins are involved in genome maintenance, as those 
constituting the DNA damage response (Sholes et al. 2001). This 
observation suggests that Ty1 transposition levels can be modulated in 
response to alterations of genome integrity and, generalizing, that 
mutations in genes implicated in genome integrity maintenance, as 
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RNase H1 and H2, could strongly alter the control mechanisms of 
transposons mobility with consequences, for different species, yet to be 
explored. 
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Aim of the projects 
 
 
 
Project 1: Investigating the role of TLS 
polymerases during genomic-rNMPs tolerance in 
S. cerevisiae 
 
Both repair and tolerance mechanisms represent important cellular 
defensive weapons against the copious different attacks coming from 
different sources. 
Among the factors that can be considered as a DNA damage, there are 
ribonucleotides;  recent evidence proves a massive ribonucleotides 
incorporation in genomic DNA, which was shown to promote genome 
instability (Nick McElhinny et al. 2010a, b). 
RNases H are the principal enzymes able to repair this type of damage 
removing, independently from the sequence, RNA associated with 
DNA. Indeed, our group described a crucial function for RNase H 
enzymes in overcoming ribonucleotides wrongly incorporated during 
DNA replication (Lazzaro et al. 2012).  
Moreover, the same study demonstrated a significant contribution of 
Translesion Synthesis pathway to the survival of cells whose genome 
is contaminated by ribonucleotides. 
The work described in this thesis is aimed at a deeper exploration of 
the interplay of the three different TLS Polymerases (Rev1, Pol  and 
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Pol ) during genomic-rNMPs tolerance, in absence of RNase H 
activity and its possible role in rNMPs incorporation. 
 
 
Project 2: Investigating the role of RNase H in S. 
cerevisiae retrotransposon metabolism 
 
Mutations of the genes coding for RNase H2 subunits cause Aicardi-
Goutiéres syndrome in humans, a genetic neurodegenerative disease 
associated with a perturbation of interferon  metabolism. At the 
molecular level, the pathogenesis of this syndrome has been attributed 
to an alteration of the metabolism of intracellular nucleic acids, 
because of the fact that the mutations identified in the genome of AGS 
patients include several genes encoding enzymes involved in the 
processing of  nucleic acids: TREX1, SAMHD1 and ADAR1, other 
than RNase H2 genes.  
Moreover, during last years in AGS patients have also been found 
mutations in IFIH1, a gene coding for a receptor able to recognize 
dsRNA and activate the antiviral responses. 
Not surprisingly, the typical symptoms of the disease are very 
reminiscent of those of congenital viral infections, although in the 
blood and in the cerebrospinal fluid of AGS patients are not found 
viruses.  
The immune response caused by RNA:DNA hybrids derived from 
endogenous retroelements would be the same that is activated in the 
presence of hybrids belonging to retroviruses; consequently, an 
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interesting hypothesis states that, in absence of the RNase H2, 
RNA:DNA hybrids resulting from the metabolism of endogenous 
retroelements accumulate in cell cytoplasm in an uncontrolled way, 
thereby triggering the abnormal production of IFN  and the resulting 
immune response. 
Then, we decided to better investigate the role of RNase H enzymes in 
the metabolism of retrotransposons using an engineered version of S. 
cerevisiae Ty1 retrotransposon. Furthermore, S. cerevisiae cells have 
proven to be a good model organism for the study of AGS because 
genes coding for the human RNase H2 (RNASEH2A, RNASEH2B, 
RNASEH2C) are able to complement the lack of yeast genes 
(RNH201, RNH202, RNH203) in removing rNMPs incorporated 
during DNA replication (unpublished data, see Figure 16); given that, 
we started studying also the effects of some AGS mutations on the 
mobility of retroelements in yeast. 
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Materials and Methods 
 
 
 
Yeast strains and media 
 
All the strains used in the project 2 of my PhD thesis are derivatives of 
SY2080 strain (W303 MATa ade2-1 trp1-1 leu2-3,112 his3-11,15 
ura3-1 can1-100 RAD5) and are listed in the table below.  
Specifying that for solid media 2% Agar was added to the liquid media 
composition, the media used in this study for budding yeast growth 
are: 
1. Rich media (YPD), composed of 1% yeast extract, 2% peptone 
and 2% glucose in bidistilled water; 
2. Minimal media (YNB + 2% glucose), containing 6.7% yeast 
nitrogen base (YNB), 1.25 g/l of threonine, 0.625 g/l each of 
phenylalanine, tyrosine, lysine, isoleucine, arginine, methionine 
and adenine and 2% glucose in bidistilled water; 
3. Synthetic complete media (YNB complete) containing minimal 
media (YNB + 2% glucose) supplemented with 25 mg/l each of 
uracil, tryptophan, adenine, histidine and leucine in bidistilled 
water; 
4. Selective media (YNB + 2% glucose, -selective amino acid) 
containing synthetic complete media with the selected amino acid 
omitted from the mixture for selective growth. 
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After preparation, all the solutions are autoclaved to ensure their 
sterility. 
 
Strain 
Name 
Genotype 
Source/ 
Reference 
YFL2208#82 SY2080 MATa Ty1H3mHIS3AI his3:: 
Available in 
Lab. 
YFL2233/2d 
SY2080 MATa rtt101::KANMX6 
Ty1H3mHIS3AI#82 his3:: 
This Thesis  
YFL2246/6b 
SY2080 MATa rnh1::HPH 
Ty1H3mHIS3AI#82 his3:: 
This Thesis  
YFL2230/13a 
SY2080 MATa rnh201::KANMX6 
Ty1H3mHIS3AI#82 his3:: 
This Thesis  
YFL2227/1b 
SY2080 MATa rnh1::HPH rnh201::KANMX6 
Ty1H3mHIS3AI#82 his3:: 
This Thesis  
YFL2229/5c 
SY2080 MATa rnh1::HPH rnh201::KANMX6 
Ty1H3mHIS3AI#82 his3:: 
This Thesis  
YFL2234 
SY2080 MATa Ty1H3mHIS3AI#82 his3:: + 
pRS316, yCp-lac111, pRS314+pADH 
(obtained from YFL2208#82) 
This Thesis  
YFL2236 
SY2080 MATa rnh1::HPH rnh201::KANMX6 
Ty1H3mHIS3AI#82 his3:: + pRS316, yCp-
lac111, pRS314+pADH (obtained from 
YFL2227/1b) 
This Thesis  
YFL2238 
SY2080 MATa rnh1::HPH rnh201::KANMX6 
Ty1H3mHIS3AI#82 his3:: + pFL93.1, 
pFL103.4, pFL105.2 (obtained from 
YFL2227/1b) 
This Thesis  
YFL2240 
SY2080 MATa rnh1::HPH rnh201::KANMX6 
Ty1H3mHIS3AI#82 his3:: + pFL112, 
pFL103.4, pFL105.2 (obtained from 
YFL2227/1b) 
This Thesis  
YFL2242 
SY2080 MATa rnh1::HPH rnh201::KANMX6 
Ty1H3mHIS3AI#82 his3:: + pFL93.1, pFL113, 
pFL105.2 (obtained from YFL2227/1b) 
This Thesis  
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YFL2244 
SY2080 MATa rnh1::HPH rnh201::KANMX6 
Ty1H3mHIS3AI#82 his3:: + pFL93.1, pFL116, 
pFL105.2 (obtained from YFL2227/1b) 
This Thesis  
 
 
Plasmids 
 
1. pRS316: yeast centromere vector with a URA3 and a AMPR 
markers; 
2. pRS314+pADH: yeast centromere vector pRS314, consisting of 
TRP and AMP
R
 markers, in which was added S. cerevisiae ADH1 
promoter; 
3. yCp-lac111: yeast centromere vector with LEU2 and AMPR 
markers; 
4. pFL93.1: yeast centromere vector (derived from pRS314) with 
RNASEH2A gene, coding for the subunit A of human RNase H2, 
under S. cerevisiae ADH1 promoter control; 
5. pFL103.4: yeast centromere vector (derived from pRS316)  with 
RNASEH2B gene, coding for the subunit B of human RNase H2, 
under S. cerevisiae ADH1 promoter control; 
6. pFL105.2: yeast centromere vector (derived from yCp-lac111) 
with RNASEH2C, gene coding for the subunit C of human RNase 
H2, under S. cerevisiae ADH1 promoter control; 
7. pFL112: yeast centromere vector (derived from pRS314) with a 
mutated RNASEH2A gene, coding for the subunit A of human 
RNase H2 carrying G37S mutation, under S. cerevisiae ADH1 
promoter control; 
Materials and Methods 
 58 
8. pFL113: yeast centromere vector (derived from pRS316) with a 
mutated RNASEH2B gene, coding for the subunit B of human 
RNase H2 carrying T163I mutation, under S. cerevisiae ADH1 
promoter control; 
9. pFL116: yeast centromere vector (derived from pRS316) with a 
mutated RNASEH2B gene, coding for the subunit B of human 
RNase H2 carrying A177T mutation, under S. cerevisiae ADH1 
promoter control. 
 
 
S. cerevisiae transformation  
 
10 ml of cell culture in exponential phase of growth for each 
transformation reaction (  5  10
6
 cells/ml) is centrifuged at 4000 rpm 
for 2 minutes at room temperature. The cell pellet is washed with 25 
ml of sterile water and centrifuged again at 4000 rpm for 2 minutes. It 
is then resuspended in 1 ml of 0.1 M lithium acetate (LiAc) and the 
suspension is transferred to a new microcentrifuge tube. 
Cells are centrifuged at 14000 rpm for 30 seconds and resuspended in 
100 l of sterile water for each transformation reaction. Aliquots of 
100 l are thus transferred to a new sterile microcentrifuge tube, cells 
are centrifuged and the pellet is resuspended in 360 l of freshly 
prepared T-Mix, composed of 240 l of 50% weight/volume 
Polyethylene glycol (PEG), 36 l of 1M LiAc, 10 l of 10 mg/ml 
carrier DNA and 74 l of sterile water. A suitable amount of plasmid 
DNA to be transformed is then added to the solution, cells are gently 
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resuspended and incubated at 42 ° C for 20 minutes, to allow the DNA 
to enter the cells. The pellet obtained by centrifuging again at 2000 
rpm for 2 minutes is washed with 1 ml of sterile water. Finally, cells 
are plated on the appropriate medium to select for transformants 
containing the introduced plasmid/plasmids. 
 
 
Ty1 mobility assay: the fluctuation analysis and 
the Lea-Coulson median estimator 
 
The purpose of the assay is to estimate the frequency of 
retrotransposition of the genomic Ty1H3mHIS3AI element in cultures 
of yeast strains having different genetic background. 
The fluctuation analysis begins when each yeast strain is streaked on 
solid medium in order to allow single colonies to grow, and incubated 
at 20 °C for four days. At this temperature, the frequency of 
transposition increases about 10 times compared to frequency at 28°C. 
At least nine colonies for each strain, chosen to represent the particular 
yeast population, are separately inoculated in 5 ml of liquid medium in 
the absence of selective pressure and incubated at 20 °C for four days. 
In this way cultures are allowed to grow to saturation and each of them 
would not contain preexisting mutants. Then, a culture aliquot is plated 
on medium lacking histidine (His
-
) and incubated at 28 °C for three 
days, so that only the His
+ 
mutant cells, in which Ty1 has 
retrotransposed, generate colonies. In parallel, an appropriate dilution 
of the initial culture is plated onto medium containing histidine (His
+
), 
as a control of the total number of plated cells. Finally, the number of 
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grown colonies is recorded and the Ty1H3mHIS3AI retrotransposition 
rates are calculated through the Lea-Coulson method of the median.  
The main parameters which must be considered to apply this method 
are: m, the number of mutations (retrotransposition events in this case) 
per culture, and r, the number of mutants per culture. The distribution 
of the numbers of mutant among the parallel cultures, derived from r, 
is used to calculate m thanks to the following equation:   
 
Finally, the estimated value of m can be divided by the total number of 
cell divisions (number of cells-1) to give the mutation rate. The Lea-
Coulson method is valid only if the value of m is between 1.5 and 15 
and if the median number of retrotransposition events in a culture is 
between 2.5 and 60 (Foster 2006; Pope et al. 2008). 
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Main Results 
 
 
 
Project 2: 
 
1. Analysis of the role of RNase H in controlling 
the mobility of retroelements in yeast 
 
Retrotransposons replicate through a “copy and paste” mechanism, 
inserting new copies of themselves into unique genomic positions. 
However, this is a rare phenomenon, typically occurring approximately 
one time per 10000 cells (Risler et al. 2012), mainly because 
retrotransposons are powerful insertional mutagens and their 
movements are controlled. For this reason, in order to facilitate the 
monitoring of transposition events in our study, we used the 
retrotransposition indicator gene his3AI, a phenotypic marker that 
helped us to understand how the transposition of the Ty1 element is 
controlled (Curcio and Garfinkel 1991). Ty1H3mHIS3AI construct 
consists of the genomic Ty1 element gene, the yeast HIS3 gene, which 
is in the opposite transcriptional orientation relative to Ty1, and an 
artificial intron (AI) that disrupts the HIS3 coding sequence and is in 
an antisense orientation relative to the HIS3 gene. In this way, the 
intron can be removed by splicing only when Ty1 is transcribed, so the 
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mobility of Ty1H3mHIS3AI element is detected phenotypically by the 
formation of His
+
 prototrophs (Fig. 14). 
 
 
 
 
 
 
 
 
Figure 14: How to detect the retrotransposition of a Ty element marked with 
the indicator gene his3AI. 
Due to the antisense orientation of the artificial intron (AI) relative to HIS3, a cell 
hosting the Ty1 element (blue line) marked with his3AI within its genome is 
phenotypically His-. When the splicing of the transcripts occurs, the AI sequence 
is removed from the Ty1 RNA and this one can be used as a template for reverse 
transcription. In this way, a new DNA copy of the element will be synthesized 
and will contain a functional HIS3 gene, which would render the cell 
phenotypically His+. (from Curcio and Garfinkel 1991). 
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1.1. Loss of RNase H1 and H2 genes results in a 
significant increase in Ty1 mobility 
 
Yeast strains containing a single intact copy of the Ty1H3mHIS3AI 
element (meaning that it retains the intron sequence) integrated in a 
random location of their genomic DNA were used in an assay to 
measure the retrotransposition frequency. Given that our hypothesis is 
that the RNase H enzymes could have a role in the degradation of the 
RNA component of the RNA:DNA hybrids, thus supporting or 
blocking the movement of transposable elements throughout the 
genome, retrotransposition frequency was measured for strains lacking 
RNase H1 or H2 activity or both. As a positive control was used a 
strain bearing the deletion of RTT101 gene, encoding the cullin-
component of an E3 ubiquitin ligase (Fujii et al. 2009), identified as 
one of the “regulation of Ty1 transposition” genes of S. cerevisiae. The 
retrotransposition frequency of this mutant is higher then wt (Scholes 
et al. 2001). 
The lack of both RNase H enzymes seems to considerably affect the 
mobility of the Ty1H3mHIS3AI retroelement: the retrotransposition 
frequency in these cells is higher than that observed in the wild type 
strain (Fig. 15). From this experiment it seems that host cell RNase H 
have a negative role in the control of retroelements mobility.  
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On the other hand, the two strains devoid of a single RNase H show 
retrotransposition frequencies very similar to those observed in the wt 
strain, indicating that in the control of the mobility of retroelements, as 
well as for hydroxyurea sensitivity (Lazzaro et al. 2012), the role of the 
two yeast RNase H is redundant. As expected, the rtt101Δ positive 
control shows a very high frequency of retrotransposition compared to 
wt strain, confirming the validity of the test. 
Future analysis will be conducted to analyze the effect of RNase H 
enzymes on the moving of Ty1H3mHIS3AI element integrated in 
different positions of the genome in order to assess whether a different 
site of integration may influence how these enzymes play their role. 
 
 
Figure 15: Loss of RNase H1 and H2 genes results in a significant increase in Ty1 
mobility.  
To detect spontaneous Ty1 retrotransposition events in strains bearing the 
Ty1H3mHIS3AI element, cells were streaked for single colonies on YPD plates and 
incubated at 20 °C for four days. Nine colonies for each strain were separately 
inoculated in YPD and incubated at 20°C for four days. Then, a colture aliquot was 
plated on medium lacking histidine and incubated at 28°C for three days. Quantitative 
Ty1H3mHIS3AI retrotransposition rates and confidence levels were calculated through 
the Lea-Coulson median test. Two strains with the same genotype (rnh1Δ rnh201Δ) 
were analyzed. Numbers in parentheses represent 95% confidence levels. 
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2. Investigating the effect of AGS mutations on 
human RNase H2 during the control of 
retrotrasposon mobility in yeast 
 
As explained in the introduction, mutations in the genes coding for the 
RNase H2 cause Aicardi-Goutères (AGS) in humans. Almost all the 
mutations identified until now in AGS patients are found into genes 
coding for enzymes involved in the metabolism of nucleic acids. For 
this reason, the Aicardi-Goutières syndrome is thought to be caused by 
an incorrect intracellular nucleic acid metabolism. If not properly 
processed, intracellular nucleic acids may result in a continuous and 
high production of IFN  and in the consequent chronic activation of 
the immune system (Chahwan and Chahwan 2012). 
Since the previous experimental data suggest that functional RNase H 
enzymes may reduce the number of retrotransposition events, probably 
facilitating the degradation of a metabolic intermediate necessary for 
the pathway, we hypothesized that a family of incorrectly processed 
nucleic acids in AGS patients cells could just  be endogenous 
retroelements. This could explain the immune response outbreak 
without any virus has been detected in patients and than provide an 
answer to the open questions about the pathogenesis. 
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2.1. G37S mutation in human RNase H2A subunit causes 
the increasing of Ty1 element mobility 
 
Recent experiments performed in our laboratory show that the three 
genes coding for the subunits of human RNase H2, introduced into 
yeast cells lacking the respective endogenous genes other than RNase 
H1 gene, produce a protein complex able to complement the absence 
of the yeast RNase H2. Transformed yeast RNase H deficient cells 
with genes encoding for human RNase H subunits, in fact, recover the 
sensitivity to a replication stress-inducing agent, hydroxyurea (HU) 
(Fig. 16), typical of cells lacking RNase H enzymatic activity (Lazzaro 
et al. 2012). 
We then decided to check the accuracy of our previous deductions and 
possibly confirm, through this assay, that the human proteins are able 
to functionally replace those of budding yeast. At the same time, the 
goal of this experiment was to assess whether the mutations 
responsible for the onset of AGS can alter the retrotransposition 
control mechanisms. 
 
 
Figure 16: The human heterotrimeric complex fully complement the HU 
sensitivity due to the deletion of yeast RNase H2. 
Sensitivity to sublethal doses of HU of the indicated strains was assayed plating 10-
fold serial dilutions on selective medium plates lacking leucine, tryptophan and uracil 
(selective markers for human RNase H2 subunits genes) and incubated at 28 °C for 
two days. rnh2Δ comprises rnh201Δ rnh202Δ rnh203Δ. 
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We then transformed yeast strains having the Ty1H3mHIS3AI element 
integrated in the genomic DNA, analyzed in the previous experiment, 
with vectors carrying the human genes of the RNase H2 subunits either 
wild type or mutated. In particular, tested mutations are: RNASEH2A-
G37S (G37S), RNASEH2B-T163I (T163I) and RNASEH2B-A177T 
(A177T), typical of AGS. The obtained strains underwent a 
retrotransposition assay to derive the frequency of retrotransposition of 
endogenous Ty1H3mHIS3AI and, also in this case, the resulting data 
were analyzed with the median test of Lea-Coulson.  
As shown in the figure 17, the genes coding for the human RNase H2 
are not able to fully complement the phenotype due to the absence of 
the corresponding yeast genes. Indeed, the frequency of 
retrotransposition of rnh1Δ rnh201Δ cells expressing the wild type 
form of the hRNase H2 is higher than that of wild type cells. Despite 
this, the catalytic G37S mutant shows a frequency of retrotransposition 
comparable to the control strain devoid RNase H activity (Fig. 17). 
Since from previous in vitro experiments we know that this mutation 
affects almost completely the catalytic activity of the enzyme (Shaban 
et al. 2010), we expected the observed phenotype. 
The T163I and A177T mutations within the B subunit, conversely, 
induce within the cell a frequency of retrotransposition very similar to 
that observed in the strain rnh1Δ rnh201Δ expressing the wild type 
version of the hRNase H2. This reveals that these mutations, in this 
assay, do not seem to alter the activity of RNase H2 (Fig. 17). 
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Figure 17: G37S mutation of the human RNase H2 subunit A induces an 
increase in Ty1 mobility comparable to the one due to the loss of the enzyme.  
Because the three different human genes, coding for the three subunits of the 
RNase H2, are localized on three centromeric plasmids into the yeast cells, the 
strains were streaked on selective medium plates lacking leucine, tryptophan and 
uracil and incubated at 20 °C for four days. Fifteen colonies for each strain were 
separately inoculated in the same type of medium and incubated at 20 °C for four 
days. Then, a colture aliquot was plated on medium lacking also histidine and 
incubated at 28 °C for three days. Quantitative Ty1H3mHIS3AI retrotransposition 
rates and confidence levels were calculated through the Lea-Coulson median test. 
Numbers in parentheses represent 95% confidence levels. 
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Conclusions and future perspectives 
 
 
 
The functioning of many molecular processes of a cell can not be fully 
understood without a deep understanding of RNA metabolism. An 
important and highly conserved component of RNA metabolism is 
represented by RNA degradation. This biological system is responsible 
for monitoring and adapting to the cell needs the levels of different 
types of RNA, including above all messenger RNAs (mRNA), which 
amounts is necessary for the ordinary post-transcriptional control of 
gene expression (Arraiano et al. 2010). Aside from the global 
regulatory network, RNA degradation is crucial also for some genome 
integrity surveillance processes or defense mechanisms against viral 
infections; indeed, the accumulation of misincorporated 
ribonucleotides during DNA synthesis has been suggested as one of 
the most common types of DNA damage (Dalgaard et al. 2012) and the 
importance of  cytoplasmic viral nucleic acids destruction has long 
been known (Goubau et al. 2013; Akira et al. 2006). 
Ribonucleases are the main actors involved in RNA degradation and 
processing activities and they have been extensively studied; however, 
the complete repertory of their RNA substrates is still misconceived, 
even for well known Ribonucleases as RNase H. Eukaryotes and 
prokaryotes are endowed with either type I or type II RNase H, able to 
process RNA molecules belonging to RNA/DNA hybrids (Cerritielli 
and Crouch 2009). However, it is very recent the discovery of an ad 
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hoc pathway for the processing of double stranded genomic DNA 
tracts contaminated with even a single ribonucleotide (Sparks et al. 
2012). In parallel, little is known about the role of endogenous RNase 
H in retroviral replication inside a host cell (Broecker et al. 2012) and 
which pathway could be affected by RNase H malfunctioning in 
human cells that then fires up rare genetic diseases, like the 
autoimmune Aicardi Goutieres Syndrome (AGS). 
The purpose of this thesis was to explore the molecular pathways and 
consequences arising in absence of RNase H enzymes or in presence of 
different mutated RNase H2 versions, responsible for AGS 
pathogenesis in human, using S. cerevisiae as experimental model. 
Cells lacking RNase H activity accumulate ribonucleotides in the 
genome, thus suffering of replication stress and genome instability; 
these cells can survive thanks to the Post-Replication Repair (Lazzaro 
et al. 2012), including a mutagenic pathway that relies on the ability of 
particular polymerases to replicate across damaged DNA, the 
Translesion Synthesis (TLS). From a previous study we knew that Pol 
 efficiently replicates rNMPs-containing DNA and that Rev1 plays a 
non-catalytic role in enhancing this function (Lazzaro et al. 2012). In 
this study we surprisingly observed that Rev1 has also a non-catalytic 
role in preventing Pol  activity, which in stressing condition due to 
the absence of RNase H and to hydroxyurea (HU) treatment, induce 
cell lethality. Furthermore, we provide evidence that Pol  toxicity 
observed in absence of RNase H is dependent on its polymerase 
activity and that is caused by its tendency to introduce an high number 
of rNMPs during the translesion synthesis when the dNTPs levels are 
downregulated by HU. It would be very interesting understand why 
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Pol  introduces ribonucleotides into the genome, if this effect is due 
only to the low concentration of available dNTPs or if it is driven by 
unusual structures in the DNA template, as previously fixed 
ribonucleotides. This last hypothesis would entail the formation of a 
toxic intermediate, maybe composed by ribonucleotides facing each 
other, responsible for multiple fractures in the DNA chains, which in 
turn would be responsible for cell death.  
In addition, more work is required to further investigate how the TLS 
polymerases compete during translesion synthesis in response to dNTP 
pool size shrinkage and if is there a competition between Rev1 and Pol 
 for Ub-PCNA binding. 
Our findings describe an unexpected mechanism for TLS that, 
resulting in increased genomic DNA damage, could be relevant to 
understand the replication stress cause in cells defective of RNase H, 
including humans affected from AGS; indeed, in AGS patients cells a 
chronic activation of the DNA damage response has been observed 
(Yang et al. 2007; Pizzi et al. 2015). 
On the other hand, since recent studies showed a 100% correlation 
between AGS associated mutations in RNase H2 genes and the 
presence of interferon -dependent inflammation (Rice et al. 2013), an 
emerging hypothesis envisage a possible involvement of RNase H2 in 
the same pathway that provide protection from viruses like HIV 
(Lepelley et al. 2011). Because of the absence of detectable viruses in 
AGS patients tissues, and given that another source of 
immunostimulatory nucleic acids is a class of viruses housing in the 
human genome, endogenous retroelements, we tried to better examine 
the role of RNase H in retroelement mobility control. We provide 
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evidence that in yeast both RNase H1 and RNase H2 are engaged in 
the retrotrasposition control pathway and that their role is clearly 
inhibitory. Probably, in the presence of functional RNase H the reverse 
transcription, a determinant step for retroelement transposition, can not 
be completed due to the degradation of RNA/DNA hybrids, as already 
suggested by the results of in vitro and in vivo experiments on 
Escherichia coli RNase HI (Ma and Crouch 1996). Conversely, loss of 
RNase H activity could result in the high accumulation of retroelement 
intermediates, which could then activate the innate immune response.  
Moreover, our results on cells transformed with mutated RNase H2 
genes confirm that G37S mutation significantly affects the catalytic 
activity of the complex (Shaban et al. 2010), that in our case is 
manifested in a loss of the ability to prevent retrotransposition events.  
Nevertheless, many open questions remains. For example, which of the 
nucleic acid intermediates forming during retrotransposition could 
have the crucial role in triggering the aberrant immune response? Why, 
in AGS patients, also RNase H2 mutations not compromising the 
catalytic activity of the enzyme can induce the interferon -mediated 
inflammation? 
Hopefully, continued investigations will shine lights on these questions 
and on the complete biological relevance of RNase H activity. 
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Abstract 
 
Accumulation of rNMPs in genomic DNA causes replication stress and 
has toxic consequences for the cells, particularly in the absence of 
RNases H enzymes required to remove them. In this situation DNA 
damage tolerance mechanisms are required for cell survival. Here, we 
investigated the contribution of three Translesion Synthesis (TLS) 
Polymerases (Rev1, Pol  and Pol ) to rNMPs incorporation in the 
budding yeast genome and in rNMPs tolerance mechanisms. We 
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previously demonstrated that Pol  efficiently replicates rNMPs-
containing DNA and that Rev1 plays a non-catalytic role in supporting 
this function. Here we found that Rev1 has a non-catalytic role also in 
preventing a toxic effect of Pol . Indeed, the polymerase activity of 
Pol  is toxic for cells in which dNTPs pool expansion is prevented, 
inducing cell death when RNases H are missing. Furthermore, we 
provide evidence that Pol  toxicity is due to its tendency to introduce 
higher levels of rNMPs  during the TLS process when the dNTPs level 
is low. These findings highligth an unexpected mechanism for TLS 
that can cause replication stress in cells defective in RNases H, a 
situation which is present in the majority of patients suffering the 
Aicardi-Goutieres Syndrome. 
 
 
Author Summary 
 
Genomic DNA is continuously damaged by misinsertion of 
ribonucleotides. Normally, inserted rNMPs are removed by 
Ribonucleases H (RNases H), able to cleave the RNA component of 
RNA:DNA hybrid molecules. Cells lacking RNase H activity can 
survive thanks to tolerance mechanisms that permit the completion of 
DNA synthesis despite the presence of DNA lesions in an error-free or 
-prone manner, depending on the type of damage and the pathway 
involved. We show that accumulation of rNMPs in the yeast genome 
cause the recruiting of polymerase  (Pol ), a translesion synthesis 
(TLS) polymerase, which is able to introduce ribonucleotides in the 
newly synthesized DNA strand and induce cell death. We also 
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demonstrate that Rev1 can prevent this Pol  toxic effect. These 
findings are important for a better understanding of the TLS 
mechanisms and explain how replication stress is arising in the 
absence of RNase H activities.  
 
 
Introduction 
 
The accuracy of DNA replication is a key factor required for the 
correct transmission of an intact genetic information to daughter cells. 
Errors during DNA synthesis, although required for evolution, 
represent a powerful source of detrimental mutations and may become 
major causes for genome instability, cancer predisposition and genetic 
diseases.  
Several biochemical processes exist to guarantee replicative DNA 
polymerases fidelity, such as their proofreading activity and the 
evolutionary conserved structural characteristics of the catalytic site 
which are responsible for water molecules insulation of the catalytic 
pocket, selectivity of correct nucleotide incorporation and the stringent 
steric selection on base pair shape and size within the active site [1-3] 
Despite this, the misinsertion of ribonucleotides (rNMPs) in place of 
deoxyribonucleotides (dNTPs) in genomic DNA during DNA 
synthesis was recently detected to occur quite frequently in normal 
cells [4,5]. The pool of rNTPs significantly exceeds that of dNTPs both 
in prokaryotes [6] and in eukaryotes [5] and often replicative 
polymerases fail in discriminating between ribose and deoxyribose 
sugars [4]. Human Pol  can incorporate one rNTP every 2.000 
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dNTPs [5] and it has been calculated that an amount of rNMPs 
exceeding ten thousand/ yeast cell, and a million/mouse cell is inserted 
into genomic DNA during each cell cycle. Therefore, incorporation of 
rNMPS into DNA genomes can be considered as the most frequent 
source of cellular DNA damage in eukaryotic cells [4,7]. Replicative 
polymerases can potentially correct this mistakes using their 3’ to 5’ 
exonuclease activity [5], but if this repair process fails rNMPs would 
remain permanently incorporated in the genome. 
rNMPs embedded in DNA molecules are mutagenic [8] and lead to 
genome instability [4]. The presence of rNMPs in DNA can also alter 
the B-conformation of a dsDNA helix [9-11] and negatively affect the 
proper assembly of nucleosomes [12]. Finally the presence of rNMPs 
may render chromosomes unstable since RNA is more susceptible than 
DNA to spontaneous hydrolysis [13] and can sensitize the DNA 
backbone to enzymatic nicking, as in the case of topoisomerase I-
dependent rNMPs processing [14,15]. 
Unrepaired rNMPs in genomic DNA would impact on normal cell-
cycle progression when a RNA-containing DNA template must be 
duplicated in the subsequent S-phase. In fact, replicative polymerases 
are not able to replicate rNMPs containing DNA [16,17], resulting in 
fork stalling, fork collapse and then replication stress. Previous work in 
several laboratories indicates that replication errors or replication 
failures are the main origins of genome instability [2,18,19].  
The enzymes responsible for rNMPs removal from DNA, are 
Ribonucleases H (RNases H) which hydrolyze the RNA component of 
DNA:RNA hybrids molecules and these enzymes are conserved  in all 
kingdoms of life [20,21]. They are involved in many cellular 
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processes, such as Okazaki fragments maturation [22] or R-loops 
removal [23]. There are two main types of RNases H: RNase H1 and 
RNase H2 [24]: RNase H2 can recognize a single rNMP within a DNA 
duplex substrate and cleave its 5’-phosphodiester bond [21,25,26], 
while RNase H1 requires the recognition of at least four consecutive 
rNMPs for nicking [27]. 
Recently, the Ribonucleotide Excision Repair mechanism (RER) has 
been characterized as a complete repair mechanism to remove rNMPs 
embedded in DNA and the main enzyme involved in this pathway is 
RNase H2. The mechanistic details of toxic rNMPs removal have been 
reconstituted in vitro: RNase H2 is required for the incision of the 
duplex, Fen1 or Exo1 endonucleases for flap ejection, Pol  or Pol  
polymerases together with the PCNA clamp and RFC complexes for 
DNA re-synthesis, and DNA ligase I for nick sealing [28,29]. 
RNase H activity is crucial for the repair of rNTPs incorporated in 
DNA in S. cerevisiae [17,30] and its role in the preservation of genome 
integrity through rNTPs removal is conserved in mammals [7,31,32]. 
Concomitant loss of RNase H1 and RNase H2 in yeast demonstrate 
that RNase H1 cooperates with RNase H2 in eliminating rNMPs from 
the chromosomes and suggests that DNA polymerases can incorporate 
in some cases more then 4 consecutive rNMPs or clustered regions of 
rNMPs that can be processed by RNase H1 [17]. 
Loss of RNase H activity may have devastating consequences; indeed, 
mutations in the three human  RNase H2 genes coding for the RNase 
H2 protein complex are found in ~ 60% of the Aicardi-Goutieres 
(AGS) patients. AGS is an autoimmunity-linked neurological disorder 
whose clinical characteristics mimic those of congenital viral 
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infections. Several studies indicate that AGS pathogenetic mechanisms 
may be linked to the formation of nucleic acid derivatives arising from 
altered repair of RNA-contaminated DNA [33-35].[32] 
When the repair pathways are saturated or incapable of replication-
blocking lesions removal before the S-phase beginning, Post-
Replication Repair (PRR) facilitate cell survival by promoting the 
completion of the replication process, without mediating lesions repair, 
according to the “better safe than sorry” philosophy [36,37]. Damage 
tolerance mechanism is composed of two parallel sub-pathways, 
Template Switching (TS) and Translesion Synthesis (TLS). PCNA is 
the key regulator of pathway selection: in fact, its post-translational 
modifications direct damage bypass into one of the alternative sub-
pathways [38-40]. TLS includes different specialized DNA 
polymerases capable of incorporating a nucleotide opposite to a lesion 
despite the conformational obstacles that most of the DNA lesions may 
impose [36,41]. In contrast to the replicative DNA polymerases, they 
have a more flexible active site that allows the accommodation of large 
bulky adducts [36,42] unable to fit into the active site of replicative 
polymerases. Moreover, they are non-processive and low-fidelity 
enzymes having lost the proofreading exonuclease activity [41,43]. 
Budding yeast has three TLS polymerases: Pol , Rev1 and Pol  [44]. 
DNA Pol  is a heterodimer consisting of the Rev3 catalytic subunit 
and the Rev7 accessory subunit, which is able to boost the polymerase 
activity of Rev3 by about 200-fold [45]. Yeast cells lacking RNase H1 
and H2 can use Pol  to bypass embedded rNMPs, as it can efficiently 
replicates over 1 to 4 consecutive ribonucleotides [17]. Moreover, the 
same study demonstrated that Rev1 plays a non-catalytic role 
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supporting Pol function. Conversely, the contribution of Pol  to the 
tolerance of rNTPs has not yet been clarified, but in a previous study 
we observed that loss of this enzyme confers an unforeseen growth 
advantage when genomic DNA contains rNMPs [17]. 
This work was aimed to explore more deeply the interplay of these 
three TLS Polymerases (Rev1, Pol  and Pol ) during genomic-
rNMPs tolerance, in absence of RNase H activity in S. cerevisiae. Here 
we reveal an  unexpected role of Rev1 in preventing Pol  activity, 
which in low dNTPs concentration and in the absence of RNase H 
enzymes, is toxic for cells. Furthermore, we provide evidence that, in 
our experimental conditions, Pol  toxicity is due to its tendency to 
introduce an high number of rNMPs during the TLS process. 
 
 
Results 
 
1. Rev1 counteracts a putative toxic effect of Polη at low dNTPs 
concentration  
As previously mentioned, ribonucleotides (rNTPs) are incorporated 
into the genome at high levels by replicative polymerases [46] 
potentially generating endogenous replication stress and genome 
instability[4]. Unremoved rNMPs in genomic DNA would impact on 
cell-cycle progression since, at the next round of DNA replication, a 
RNA-containing DNA template must be duplicated, and replicative 
polymerases are not able to fulfill this task [16].  
Recently has been shown that budding yeast Saccharomyces cerevisiae 
cells devoid of both RNase H1 and H2 (rnh1∆ rnh201∆) can use TLS 
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and Template Switch pathways to completely replicate their rNMPs-
containing genome and survive. Moreover, in the absence of a 
functional Template Switch pathway, rNMPs-containing DNA can 
only be replicated by the action of TLS Pol  [17]. 
Surprisingly, we observed that the simultaneous deletion of all TLS 
polymerases suppresses the HU sensitivity of rnh1∆ rnh201∆ cells; in 
addition, we found that this suppression is fully recapitulated by 
deletion of the single RAD30 gene encoding TLS Pol , suggesting 
that such polymerase may have a toxic effect on cell cycle progression 
in the presence of HU [17] and Fig. 1. 
We also observed that deletion of the single REV1 gene in double 
mutant rnh1∆ rnh201∆ cells causes increased HU sensitivity although 
the Template Switch sub-pathway is fully functional. This result does 
not seem not to be related to the Rev1 role in supporting TLS Pol  
activity, since deletion of REV3 and REV7, encoding the two Pol  
subunits, has no detectable effect on HU sensitivity of rnh1∆ rnh201∆ 
mutant cells (Fig. 1a). 
On the contrary, the strong HU sensitivity of rnh1∆ rnh201∆ rev1∆ 
cells can be fully attributed to the toxicity of Pol ; indeed, it is almost 
completely suppressed by the further deletion of RAD30 gene (Fig. 1). 
This observation strongly suggests that Rev1 plays an additional role 
in preventing a Pol -dependent toxic function.  
Although cells lacking RNases H activities are sensitive to replication 
stress agents [17], our genetic analysis suggests that Pol  toxicity is 
only visible in response to HU treatment. The exposure of rnh1∆ 
rnh201∆ rad30∆ cells to another agent capable of inducing replicative 
stress, such as methyl methane sulfonate (MMS), does not produce the 
Manuscript in preparation 
 112 
same effect. Indeed, while rnh1∆ rnh201∆ cells are sensitive to MMS, 
removal of RAD30 does not suppress, but aggravates, this sensitivity 
(S1 Fig.). 
 
Figure 1. Absence of TLS Rev1 polymerase increases HU 
sensitivity of rnh1∆ rnh201∆ mutant cells, and this effect is 
abrogated when TLS  Pol  is non functional.  
A. To test sensitivity to 25mM HU 10-fold serial dilutions of the 
indicated strains were plated on YPD or YPD + 25 mM HU. B. 
Quantification of cell survival in the presence of HU was calculated by 
distributing about 100 G1-synchronized cells on solid medium with or 
without  25mM HU. Colonies were grown at 28 °C for three days and 
counted. The histogram is representative of three independent 
experiments. Error bars describe mean  ± s.e.m.  
 
2. The Rev1 catalytic activity is not required to prevent the toxic 
effect of Pol η 
We investigated whether the role of Rev1 in controlling Pol  toxicity 
in the presence of HU was linked to its enzymatic activity. As shown 
in Fig. 2, by using a catalytically dead mutant strain (rev1D467A-
E468A) (ref) we show that Rev1 polymerase activity is not required to 
prevent Pol  toxicity. In fact, the HU sensitivity of rnh1∆ rnh201∆ 
rev1∆ cells is rescued at the same level by addition of a wt version of 
REV1 or by the catalytically dead mutant of REV1 (Fig. 2). 
This finding indicates that to suppress Pol  toxicity in HU is required 
the physical presence of Rev1 and not its enzymatic activity. An 
interpretation of this result might imply a physical competition 
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between Rev1 and Pol  for the same substrate or, alternatively, Rev1 
interaction may negatively regulate Pol . 
 
Figure 2. Rev1 suppresssion of HU sensitivity in RNases H-deleted 
cells  does not require its catalytic activity.  
A. Wild-type REV1 or catalytically dead rev1D467A-E468A are able to 
recover the HU sensitivity observed in a rnh1∆ rnh201∆ rev1∆ strain. 
HU sensitivity was tested as described in Fig. 1A. 
B. Quantification of cell survival was calculated as explained in Fig. 
1B on the basis of three independent experiments. 
 
3. The catalytic activity of Pol η causes cell lethality when genomic 
DNA is rNMPs-enriched 
To analyze the contribution of Pol  in HU sensitivity when RNases H 
genes are deleted, we have overexpressed wild-type or a catalytic 
mutant form of RAD30 in a wt or rnh1∆ rnh201∆ genetic backgrounds. 
Serial cellular dilutions have been plated in absence or presence of 25 
mM HU and cell growth was measured by drop test (Fig. 3A) and cell 
survival was quantitatively evaluated (Fig. 3B). Differently from what 
observed when we analyzed Rev1 contribution to translesion synthesis 
in rnh1∆ rnh201∆ double mutant cells in the presence of HU, the 
sensitivity to the drug is clearly increased when the wt form of Pol  is 
overproduced, while this is not the case when a catalytically dead form 
of of Rad30 is overexpressed (Fig. 3B and 3C). This finding indicates 
that the toxic Pol  effect observed in the absence of RNase H 
enzymes in HU-containing media requires its catalytic activity.  
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Figure 3. Pol η is responsible in producing toxic intermediates 
causing cell lethality when rNMPs-containing DNA cannot be 
repaired.   
A. The overexpression of the wild type form of Rad30 in cells lacking 
RNase H activities induces cell death in the presence of HU. The 
sensitivity is suppressed by overexpression of a catalytically-dead 
Rad30 mutant. The sensitivity to HU was measured as described in 
Fig. 1A. 
B. Quantitative data were assayed as described in Fig. 1B. 
C. The levels of overproduced wt or mutant Rad30 forms were 
monitored by western blotting with anti-His-Tag Ab. 
 
4. The activity of Pol η increases the rNMPs levels in genomic 
DNA in the presence of HU 
It is well established that HU treatment causes a reduced concentration 
of dNTPs in the cells. Therefore, we hypothesized that in a rnh1∆ 
rnh201∆ double mutant background and in the presence of low dNTPs 
levels an aberrant replicative mechanism catalyzed by Pol  may 
introduce high rNMPs levels into the genome that, above a certain 
threshold, may be toxic for the cells. 
To verify this hypothesis, we compared the amount of ribonucleotides 
incorporated in genomic DNA during a single cell cycle in unperturbed 
conditions or in the presence of HU. As shown in Fig. 4, we observed 
that HU treatment significantly increases the levels of rNMPs 
incorporated when RNase H activities are absent. However, the highest 
level of rNMPs incorporation is observed in cells lacking both RNase 
H and Rev1 activities and in such a genetic background the 
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simultaneous deletion of RAD30 reduces the level of incorporated 
rNMPs. We interpret all these data by assuming that, in the absence of 
Rev1, Pol  gains access to DNA regions in which the replication 
process is impaired and Pol  activity is responsible for the increased 
level of rNTPs incorporation.  
 
Figure 4. Pol η toxicity is caused by its capacity to incorporate 
ribonucleotides into DNA in the presence of HU. 
HU-dependent incorporation of rNTPs by Rad30 observed in 
rnh1∆rnh201∆ cells was assayed quantifying the amount of embedded 
rNMPs in DNA. The indicated strains were arrested in G1 with alpha 
factor and then released in fresh medium with or without 50mM HU. 
When cells were in S-phase, nocodazole was added thus permitting a 
single round of replication. Genomic DNA was extracted and rNMPs 
incorporation in the genome was measured as described in Material 
and Methods. 
 
 
Discussion 
 
Recently has emerged that replicative polymerases can introduce 
rNTPs instead of dNTPs during physiological DNA replication [46] 
and that these misincorporated nucleotides represent the most abundant 
“mistake” of replicative DNA polymerases. To cope with these events, 
prokaryotic and eukaryotic cells have evolved a specialized repair 
system, called RER (Ribonucleotide Excision Repair), that removes  
rNMPs from the genome [29]. The initial step of RER requires the 
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action of a RNase H enzyme and if RER fails the cells suffer 
replication problems [4,17,32]. 
Previously we have shown that yeast and human cells can tolerate 
rNMPs-containing chromosomes through the action of a tolerance 
mechanism called Post-Replication Repair (PRR) [17]. PRR comprises 
two sub-pathways: Translesion DNA synthesis (TLS) acting through 
the action of several TLS polymerases and Template Switch (TS) 
acting through recombinational mechanisms [38]. Here, we 
investigated the role of TLS polymerase in bypassing unremoved 
rNMPs from the genome and their direct involvement in rNMPs 
incorporation. 
When ribonucleotides accumulate in genomic DNA, cells become 
sensitive to additional replication stress caused by external agents, 
such as MMS and HU, and this sensitivity dramatically increases if 
both branches of PRR are impaired [17]. Surprisingly, the single 
deletion of RAD30, the gene coding for TLS Pol η, recovers almost 
completely the HU sensitivity of yeast cells defective in both RNase 
H1 and RNase H2 (rnh1∆ rnh201∆ cells) (Fig. 1) and [17]. HU 
inhibits the ribonucelotide reductase, thus causing the depletion of the 
dNTP pools essential for DNA replication. On the contrary, the 
sensitivity to MMS, another DNA damaging agent that does not alter 
dNTP pools, is not altered by the further RAD30 deletion in RNase H 
mutant cells (S1). These data suggest that, when cells replicate DNA in 
conditions of low dNTPs concentration, Pol η plays a negative role that 
affects the replication process. 
Moreover, when Pol η is overexpressed in cells lacking RNase H 
activity, the HU sensitivity severely increases, while remains unaltered 
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in a wild-type genetic background. Conversely, the overexpression of a 
catalytic mutant form of Pol η causes an opposite effect, resulting in a 
decrease of the HU sensitivity observed in rnh1∆ rnh201∆ cells (Fig. 
3). We also noticed that the overexpression of the catalytic mutant 
form of Pol η can recover the HU sensitivity of rnh1∆ rnh201∆ cells 
also when a wild-type copy of the RAD30 gene is present, suggesting a 
dominant negative function of the catalytic mutant allele. Altogether, 
these genetic data indicate that the polymerase activity of Pol η 
generates some toxic intermediates when cells defective in any RNase 
H activity replicate their genomes in the presence of low dNTPs levels.  
To explain the phenotypes above described, we could suppose that, in 
the absence of functional RNases H, rNMPs accumulate in the genome 
and TLS polymerases are recruited to allow the completion of DNA 
replication. However, when dNTP levels are decreased as a 
consequence of HU treatment, Pol η assumes a toxic role. In a 
different, but not mutually exclusive interpretation, we can speculate 
that replicative polymerases stall in conditions of low dNTPs levels 
and are substituted by TLS polymerase and, in these conditions, Pol η 
can incorporate rNMPs more efficiently. In the absence of RNase H 
activity, this high level of Pol η-dependent rNMPs incorporation 
induces cell lethality. This hypothesis is supported by the identification 
of  a specific role of Pol η and TLS in genomic DNA replication in 
presence of HU in human [47] and E. coli [48]. Moreover, the 
monoubiquitylation of PCNA, a crucial step for activation of the TLS 
sub-pathway in PPR mechanisms, is strongly induced by HU treatment 
[49]. 
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We observed that deletion of REV1 gene, encoding a peculiar TLS 
polymerase with dCMP transferase activity [50], dramatically 
increases the sensitivity to HU of rnh1∆ rnh201∆ cells, and that this 
increased sensitivity is fully abolished by additional deletion of RAD30 
gene (Fig. 1). This function seems to be independent on the additional 
role of Rev1 in regulating TLS Pol ζ activity, because deletion of 
REV3 and REV7, encoding the catalytic and the accessory subunits of 
Pol ζ, does not alter the HU sensitivity of rnh1∆ rnh201∆ cells (Fig.1). 
Additionally, this unexpected Rev1 function is independent on its 
catalytic activity (Fig. 2). From these observations we hypothesize that 
Rev1 and Pol η likely compete for the same substrate and that Rev1 
interferes with Pol η function when the dNTP pools are low. A good 
candidate for this substrate competition is the ubiquitylated form of 
PCNA because both Rev1 and Pol η can bind the PCNA complex 
using specific domains [51,52]. Alternatively, it has been shown in 
yeast, human and mouse that Rev1 and Pol η stably interact [53-55]; 
this interaction could inhibit Pol η-dependent toxic function in low 
dNTPs concentrations. 
We hypothesized (Fig. 5) that, during replication in the presence of 
low dNTP pools, TLS polymerases are recruited on DNA as a 
consequence of replicative polymerases stalling. Rev1 can control the 
recruitment of both Pol  and Pol η, promoting the activity of the first 
while inhibiting the latter. In the absence of Rev1, Pol η can be more 
easily recruited on DNA and introduce additional rNMPs into the 
genome: this may allow completion of  replication in the presence of 
reduced dNTPs pool. In RNase H-proficient cells, the incorporated 
rNMPs may be subsequently removed but, if RNase H activity is 
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impaired, the high amount of rNMPs into the genome becomes toxic 
for the cells, finally preventing cell cycle progression. 
Consistently with this model, we demonstrated that during replication 
in HU, Pol η introduces higher rNMPs amounts especially in the 
absence of Rev1 (Fig. 4).  
In conclusion, we also identified a novel protective role for Rev1 in 
preventing genome instability, as a consequence of increased rNMPs 
misincorporation by Pol η at low levels of available dNTPs. These 
discoveries can lead to important breakthroughs in the field of 
replication stress tolerance, even if other efforts are required to better 
understand TLS mechanisms in response to dNTP pool size changes 
and RNase H deficiency. Simultaneously, our finding in S. cerevisiae 
could serve as a paradigm for tolerance processes in higher eukaryotes, 
as humans suffering from genetic disorders which plague the normal 
replication process, or Aicardi-Goutieres Syndrome, caused by 
mutations in genes coding for RNase H2 subunits. 
 
Figure 5. Hypothesized Model. 
The stalling of replicative polymerases, due to accumulated genomic 
rNMPs in absence of RNases H or to reduced dNTP pools at 
replication sites in presence of HU, allow the recruitment of TLS 
polymerases in order to complete genomic DNA sythesis. In this 
context, Pol η catalyzes the frequent incorporation of rNTPs in 
chromosomal DNA, allowing the DNA synthesis to continue. On the 
other hand, Rev1 prevents Pol η intervention, possibly by direct 
inhibition or by competition for monoubiquitylated PCNA, 
simultaneously promoting Pol  activity. Functional RNases H would 
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finally remove rNMPs inserted by Pol η and thus prevent cell 
lethality.  
 
 
Materials and methods 
 
Yeast strains, plasmids, media and growth conditions: 
All the strains in Table S1 are derivative of W303 RAD5+. Standard 
genetic procedures for cell transformation and tetrad analysis were 
used to generate them [56]. Deletions were made by the one-step PCR 
system [57]. pEGUh6-RAD30 and pEGUh6-rad30D155A,E156A 
plasmids have been kindly provided by T.A. Kunkel and are described 
in [58]. For the indicated experiments, cell cultures were grown in 
YPD medium containing 2% glucose, raffinose 3%, raffinose 3% and 
galactose 2% and enriched or not by addition of the drugs indicated in 
the Figure legends. All the experiments were performed at 28°C. 
 
DNA estraction 
Genomic DNA was extracted with the Teeny Prep method: briefly, 
yeast spheroplasts were prepared with sorbitol 1 M, EDTA 0.1 M, 2-
mercaptoethanol 14 mM and zymoliase 1 mg/ml (US Biological) at 37 
°C, followed by cell lysis at 65 °C for 40 min with EDTA 55 mM, 
Tris-HCl 89 mM pH 7.5, SDS 0.44% and DNA precipitation at -20 °C 
in ethanol. After DNA resuspension, samples were incubated with 
RNase A 0.05 mg/ml at 37 °C for 30 min and purified through three 
washes with equal volume of phenol. Precipitation with isopropanol 
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was performed at -20 °C, pellets were air-dried and then DNA was 
resuspended in bidistilled water. 
 
Sensitivity Assay 
To evaluate the viability of each yeast strain after HU and MMS 
treatment, cell cultures in exponential phase of growth were diluted to 
1 × 10
6
 cfu/ml, and 10-fold serial dilutions were spotted on solid 
medium enriched or not with HU or MMS at the indicated 
concentrations. Pictures of the plates were taken after 2 or 3 days of 
incubation. In parallel, in order to obtain quantitative data, 
exponentially growing cells were synchronized in the G1 phase by 
adding α-factor to 6 μg /ml. After appropriate dilutions, 100 cfu of 
each strain were plated on YPD with or without the indicated drugs. 
After 3 days of incubation the number of grown colonies was recorded. 
Experimental results were calculated from the ratio between the 
number of colonies treated or not with the drugs. The  standard error of 
mean (s.e.m.) was calculated on three independent experiments. 
 
Western Blot 
TCA protein extracts were prepared and an equal amount for each 
sample was separated by SDS-PAGE using standard technique [59]. 
Western blotting was performed with anti-HIS tag Ab  (70796-3) 
Novagen. 
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Ribonucleotides Incorporation Assay 
Yeast cell cultures in exponential phase of growth were normalized at 
6 × 10
6
 cells/ml and blocked in G1 by adding  α-factor to 6 μg /ml. 
Cells were then simultaneously collected by centrifugation and each 
strain was resuspended in fresh YPD or fresh YPD enriched with 50 
mM HU. 45 min after release from the G1 block, 20 μg /ml nocodazole 
was added to the cultures to arrest the cell cycle in M phase thus 
allowing the completion of a single cell cycle. Genomic DNA purified 
with the teeny prep protocol, digested with 0.5 U Escherichia coli 
RNase HII (New England Biolabs) in 50 µl at 37 °C for 2.5 h and 
precipitated O/N in 0.3 M sodium acetate pH 7 and ethanol at -20 °C. 
The day after, DNA was resuspended in TE 0.1%. For the subsequent 
steps we followed a previously described protocol [32]. 
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Supporting Information 
 
 
S1 Figure. Pol η is not toxic for cells devoid of RNases H activities 
in the presence of MMS. 
The figure shows that the sensitivity of rnh1∆ rnh201∆ cells to MMS 
is not dependent on the presence of a functional RAD30 gene. To test 
sensitivity to 0.01% or 0.02% MMS 10-fold serial dilutions of the 
indicated strains were plated on YPD or YPD + MMS. The photograph 
was taken after 3 days of growth. 
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 S1 Table. Strains used in this study 
 
Strain name Genotype 
Source/ 
Reference 
SY2080 
W303 MATa ade2-1 trp1-1 leu2-3,112 his3-11,15 
ura3-1 can1-100 RAD5 
M. Foiani 
YFL1213 (SY2080) MATa rnh1::HIS3 rnh201::KANMX6 [17] 
YFL1409 
(SY2080)  MATa rnh1::HIS3 rnh201::KANMX6 
rev1::KANMX 
 This study 
YFL1775 
(SY2080)  MATa rnh1::HIS3 rnh201::KANMX6 
rev1::KANMX rad30::TRP1 
 This study 
YFL1773 
(SY2080)  MATa rnh1::HIS3 rnh201::KANMX6 
rad30::TRP1 
 This study 
YFL1559  
(SY2080)  MATa rnh1::HIS3 rnh201::KANMX6 
rev1::KANMX ura3::REV1:URA3 
 This study 
YFL1577 
(SY2080)  MATa rnh1::HIS3 rnh201::KANMX6 
rev1::KANMX ura3::REV1-DE467-468AA:URA3 
 This study 
YFL1389 
(SY2080)  MATa rnh1::HIS3 rnh201::KANMX6 
rev3::TRP1 rev7::HIS3 
 This study 
YFL1271 
 (SY2080)  MATa rnh1::HIS3 rnh201::KANMX6 
rev3::TRP1 rev7::HIS3 rad30::KANMX6 
rev1::KANMX6 
[17] 
YFL1419  (SY2080) MATa + pRS426   This study 
YFL1420  (SY2080) MATa + pEGUh6-RAD30   This study 
YFL1421  (SY2080) MATa + pEGUh6-rad30D155A,E156A   This study 
YFL1422 
 (SY2080) MATa rnh1::HIS3 rnh201::KANMX6 
+pRS426 
 This study 
YFL1423 
 (SY2080) MATa rnh1::HIS3 rnh201::KANMX6 + 
pEGUh6-RAD30  
 This study 
YFL1424 
 (SY2080) MATa rnh1::HIS3 rnh201::KANMX6 + 
pEGUh6-rad30D155A,E156A  
 This study 
YSS21 (SY2080) MATa rad30::KANMX6 [60] 
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